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11. SMALL SCALE SERVICE EVALUATION PROJECT
AN EVALUATION OF THE CASELOAD AND CASEMIX OF 
A CLINICAL PSYCHOLOGY SERVICE
Written in accordance to guidelines for submission to: Journal o f Mental Health
(appendix 1.1)
RUNNING HEAD: AN EVALUATION OF CASELOAD AND CASEMIX
2ABSTRACT
The caseload and casemix of an area wide psychology service was compared across time to 
examine whether there was a proportionate increase of Reasons For Care within the caseload 
which were more demanding of time in general. All the referrals received by the service 
during two 18-month cohorts were compared in terms of client problem, Care Aim and time 
in contact.
The overall number of referrals received by the service in Cohort Two had increased. The 
proportionate frequency of referral of certain Reasons For Care had changed significantly. 
There were less anxiety, phobias, and addiction referrals. There were also significantly more 
Anger and Depression referrals. In Cohort Two there was significantly more use of 
Assessment as a Care Aim and significantly less use of Problem Resolution.
Eating Disorders and Relationship/Social problems consistently employed most time in 
contact across Cohort One and Two. The evaluation of caseload and casemix across time 
revealed that there was not a proportionate increase in Reasons For Care which were more 
demanding of time in Cohort Two. During Cohort Two increased demand was met in a 
shorter amount of time, this may have been due in part to increases in staff and the use of 
brief interventions where possible. Further service level agreements could consider head 
counts, proportions of specific Reasons For Care and the provision of long or short-term 
therapies to prevent excessive demand and increase clinical and cost effectiveness.
3Introduction 
Background
The number and type of referrals received by a clinical psychology service, has a direct 
impact on the operation of the service. Similarly the range and size of caseload of a service 
at any given point in time significantly influence practical aspects of service delivery, 
effectiveness and outcome.
In the current climate, government policies have continued to encourage service level 
agreements between Health Boards and providers, involving stipulated referral numbers and 
reduced waiting times. The result in some cases has been an increase in pressure on services 
to see as many patients as possible and to increase throughput. This has led to a greater 
emphasis on clinical and cost effectiveness within the profession (Kowalksi, 1991).
Referrers, often unaware of the resource limitations of the psychology service, refer 
increasingly regardless o f available resources. This creates long waiting lists and very large 
caseloads. Despite direct clinical work only being a part of psychologists’ workload, it often 
forms the greater part. This results in difficulty in prioritising any other professional 
activities, such as research and supervision (Norcross et al.,1992).
Anciano and Kirkpatrick (1990) reflected this view, they found psychologists received an 
“overwhelming” amount of direct clinical work, which generated higher caseloads and time 
management pressures. This finding has been replicated in other parts of the country (Carr 
1990, Newnes 1993).
4Due to the fact that clinical work often forms the greater part of any clinical psychology 
service, the NHS executive has issued a mandate for clinical psychology services to 
undertake clinical audit (DoH, 1989). Despite this, there has been little in the way of 
published literature on clinical audit in the UK (Cape, 1995b), and even less focusing on 
caseload and case-mix.
Health commissioners and providers cannot negotiate meaningful service agreements 
without further understanding of the implications of caseload and case-mix, in terms of client 
populations, presenting problems and outcomes of psychological interventions. Hill et al. 
(1999) who recently undertook a service wide clinical audit demonstrated clearly why 
caseloads cannot be determined by head counts alone. They found that a significant 
proportion of cases referred to their service had three or more referral problems (nearly half 
(47%) of referrals to Adult Mental Health AMH speciality, 35% of Child and 29% of 
Learning Disability (LD) referrals). These figures indicate a high level of complexity in 
terms of the number of pre-intervention symptoms, and time commitment for intervention in 
a large proportion of cases. Hill et al. also identified that within more than a third of cases 
additional problems arose in the duration of contact, thus rendering it virtually impossible to 
predict duration and frequency o f intervention and placing unexpected and unresourced 
demands on the service.
Evidence from the Psychotherapy Review (NHSE, 1996) suggests that some psychological 
therapies work better for particular disorders. It is only by exploring caseload and case-mix 
that psychology services can estimate the proportion of those disorders requiring either long 
term maintenance therapies, or shorter term “curative” approaches. Thus enabling them to
5negotiate more meaningful service agreements in terms of time commitment, clinical and 
cost effectiveness.
The current study is an evaluation of the referrals to and caseload of, the Consulting and 
Clinical Psychology Services (CCPS), which is the NHS area wide clinical psychology 
service for Ayrshire and Arran. Throughout its history CCPS has maintained a relatively high 
level of direct clinical work across the service. Increasingly clinical psychologists have 
gained the impression that the caseloads they manage are changing towards greater 
complexity, which can be defined in terms of proportionately more time consuming referral 
problems.
EPPIC Care Framework
In the period of 1993/94 CCPS took the lead national role as demonstrator site for the 
development of the EPPIC (effective purchasing and providing in the community) minimum 
data set which defines a broad range of clinical psychological work (Wight & McPhail, 
1995). The minimum data set encompasses; patient details, first contact and discharge dates, 
referrer details, main Care Aim coupled with main Reason For Care, recording of 
contributory factors and the main interventions employed, (see Appendix 1.2)
The maintenance of a patient database within CCPS made it possible to examine the 
accuracy and validity of the impression that caseloads are changing towards greater 
complexity. The database provided monthly updates on patients seen within the service. 
Recording of the EPPIC minimum data set on to the computerised database was completed
6for all patients seen between October 1993 and March 1998 (Unfortunately due to the lack of
resources and funding data collection ceased in March 1998).
An earlier unpublished study (Development of a costing system for CCPS) examined clinical 
contact data over an 18-month period. This study highlighted that a mixed caseload of client 
problems across all services could include a wide range of time commitments and that the 
variation can be significantly high across different problem types.
Current Study
The aim of the current evaluation was to examine whether referrals to clinical psychology 
have become more complex, in that they are more demanding o f time in general. Two 18- 
month cohorts of referrals to CCPS were compared in terms of Care Aims, client problems, 
and time in contact. Comparison of the proportionate frequency of referrals and their relative 
time commitments was made across the initial (Cohort One) and current cohort (Cohort
Two) to investigate whether there has been any change over time.
Method 
Participants
All patients referred to the Area Psychology Service (including referrals to Adult Mental 
Health, Community, Organisation, Counselling Psychology, Child Health, Elderly Care, 
Learning Disability, Health Psychology and Addictions) were logged onto 2 databases 
between 1993 and 1998. The database was re-designed between 1995 and 1996, using the 
same categories thus creating two separate, but related databases. Recording of the EPPIC
7minimum data set on the computerised databases was completed for all patients seen 
between October 1993 and March 1995 and between October 1996 and March 1998.
The Minimum data set refers to two categories:
• The Reasons For Care/Detailed Formulation category describes problems or disorders in 
psychological terms, which largely relate well to the definitions within DSM IV (see 
Appendix 1.3).
• The Care Aim category reflects the range of “Aims o f Intervention” in Clinical 
Psychology (see Appendixl.4).
In each case the psychologist involved, categorised the patient’s main Reason For Care and 
main Care Aim.
Missing data: Psychologists and secretarial staff logged data on to the PC - In both cases 
there was missing data on the computer.
Design
The current research questions were derived from an earlier study that examined clinical 
contact data over an 18-month period (October 93-March 95). That data set is referred to as 
Cohort One, and provided a breakdown of the relative frequency of the Reasons For Care 
across all referrals to the psychology service, as well as an analysis of the proportionate time 
commitments for a range of Reasons For Care. Cohort Two refers to all referrals between 
October 1996-March 1998.
For the 1996-98 data, matrices were created, which contained frequency data for the 
minimum data set (Care Aim x Reason For Care), and time-in-contact data for each Care 
Aim x Reason For Care. The cases referred to in this data set were those that were ongoing 
and newly referred and discharged within Cohort Two. Analyses of the frequency and time 
data from Cohort Two were compared to the baseline data set i.e. Cohort One, to establish 
whether there had been any change over time.
Approach to Data Analysis
The data were analysed using descriptive statistics such as frequencies, percentages, and 
means. Certain data were also plotted graphically. Categorical data were compared using chi- 
square analyses.
Results
Frequency and proportion of Reasons For Care within caseload
To examine whether the absolute or proportionate frequency of Reasons For Care arising in 
the caseload has changed over the two cohorts, the primary Reason For Care categories in 
which patients are represented only once were examined. The absolute and proportionate 
frequency of ongoing and new referrals for every specific Reason For Care for Cohort One 
and Two are contained in Table 1.
INSERT TABLE 1
9The absolute numbers refer to the total number of referrals falling within a certain 
formulation category (main Reason For Care). Both the absolute number of referrals received 
by the service and the number of referrals per Reason For Care has increased from Cohort 
One to Cohort Two. However as the number of ongoing and new referrals within the 
caseload differ across both cohorts, the proportionate frequency of the Reasons For Care 
occurring within each cohort was also examined.
Chi square analyses comparing the distributions in Cohort One and Two found significantly 
more referrals in Cohort Two for Anger (jfl = 115.9, df = 1, p < 0  .05), Depression (%2 = 
48.51, d f=1, p < 0.05) and Relationship/Social Problems (%l = 5.67, df = 1, p <0.05). There 
were also significantly less Anxiety and Phobias (%2 = 72.2, df = 1. P < 0 .05) and 
Addictions (j2  = 131.04, df=  1, p < 0.05).
Frequency and proportion of Care Aims employed
In order to evaluate if there has been any change in the usage of the main Care Aims across 
the two cohorts, the main Care Aims employed and the proportionate use of these across all 
Reasons For Care was examined in both cohorts. As only main Care Aim categories are 
being examined, patients are represented only once in the table below (see Table 2).
INSERT TABLE 2
The main Care Aims most frequently employed in Cohort One were Problem Resolution, 
Assessment, Rehabilitation and Enabling. In Cohort Two those Care Aims most frequently
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employed by psychologists were Assessment, Problem Resolution, Rehabilitation and 
Enabling.
Chi square analyses revealed that usage/employment of main Care Aims had changed 
significantly between Cohort One to Two. In Cohort Two there was significantly more usage 
of Assessment {%! = 246.94, df = 1, p < 0.05), Enabling (%l = 79.21, df =, p < 0.05), Support 
(j2  = 69.72, df = 1, p < 0.05) and Rehabilitation { j l  = 5.36, df =, p < 0.05) as Care Aims, 
and significantly less use of Problem Resolution as main Care Aim (%l -  675.98, df = l , p <  
0.05).
Time in contact across Reasons For Care
In order to investigate whether time in contact per Reason For Care had changed, the mean 
time in face to face contact (for a completed treatment episode) across the Reasons For Care 
in Cohort One and Two was examined. One time unit equates to 15 minutes( see Figure 1).
INSERT FIGURE 1
In Cohort One it was established that certain Reasons For Care were more demanding of 
time than others. PTSD, Relationship/Social problem, Problems related to Physical Illness, 
Eating Disorders and Behavioural/Movement Disorders all required more time in face to face 
contact with psychologists on average. In Cohort Two mean time in contact employed 
decreased an all Reasons For Care with the exception of OCD, Personality Disorder, 
Addictions, Sleep Disorder and Development/Speech in which mean time in contact had 
increased marginally from Cohort One to Two. Those Reasons For Care which were more
11
demanding of time in Cohort two were OCD, Relationship/Social Problems, 
Behaviour/Movement Disorder and Eating Disorder.
An inferential test such as independent t test would have demonstrated whether mean time in 
contact had changed significantly over Cohort One and Two, however this test could not be 
carried out due to the format of the raw data in Cohort One.
The total number of time units used overall in each cohort was examined. In Cohort One and 
Two 36,827and 27,914 time units were employed respectively (1 unit = 1 5  minutes and I 
appointment session is the equivalent of four time units, I.e. one hour).
Proportionate Amount of Time in contact
In order to examine whether there was an increase in the proportionate amount of time in 
contact employed by Reasons For Care across cohorts, this was calculated by dividing the 
total number of time units employed by all the cases in the cohort overall (all Reasons For 
Care) by the total time units employed by all the cases in an individual Reason For Care. 
Table 3 Highlights whether there has been any change in the amount of time employed by 
the Reason For Care categories which had employed most time in contact (per whole 
treatment episode) in Cohort One and also highlights those Reasons For Care employing 
proportionately more time in Cohort Two.
INSERT TABLE 3
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The Reasons For Care which employed most time in contact proportionately in Cohort One 
were PTSD, Problems relating to Physical Illness, Relationship/Social problems and Eating 
Disorders. The Reasons For Care which have consistently employed more time in contact 
across Cohort One and Two are Relationship/social and Eating Disorder. Additionally, OCD 
and Behaviour Movement disorders also employed proportionately more time in Cohort Two
In order to evaluate whether the proportion of completed cases changed across cohorts and 
whether or not there were proportionately more cases requiring longer term contact in Cohort 
Two, the percentage of cases where treatment was completed by the end of the two cohorts 
respectively was examined. By the end of Cohort One, 62% of referrals within the 18-month 
caseload were completed and discharged. Similarly by the end of Cohort Two, 66.5% of the 
referrals in the caseload were discharged.
Comparison of the total number of cases with the number of completed cases for every 
Reason For Care category in Cohort Two highlighted the distribution of incomplete 
treatment episodes across Reasons For Care (see Figure 2).
INSERT FIGURE 2
Figure 2 highlights that Relationship / Social problems, Anger, OCD and Anxiety & Phobia 
had the lowest proportion of completed cases, approximately 50% for each Reason For Care.
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Discussion
The purpose of the current evaluation was to examine the clinician impression that referrals 
were becoming more complex, in that they were becoming more demanding of time in 
general and proportionately speaking, arising more frequently in the caseload.
Proportionate frequency of Reasons For Care arising in the caseload/cohort
The increase in the overall number of referrals in Cohort Two could be due to a number of 
factors, including increasing demand for psychology services as people became more aware 
of psychological problems. The sharp rise could also be due to the longer tenure and 
establishment of the consulting and clinical psychology services within Ayrshire and Arran, 
and their uptake by Trusts, GP’s and GP Fundholders (CCPS just been re-configured at the 
time of the first cohort). The increased referral rate could also be due to an increase in the 
number of WTE qualified psychologists on staff in Cohort Two.
In terms of proportionate frequency of Reasons For Care arising significantly more or less in 
Cohort Two, despite a 10% decrease, Anxiety and phobias remained the most frequently 
referred Reasons For Care. The significant decrease in numbers of Addictions was due in 
part to the departure of a specialist psychologist who was not replaced after Cohort One. 
Increased familiarity with the EPPIC categories could account for the significant decrease in 
numbers of cases labelled Other in Cohort Two. The Proportionate frequencies o f Anger and 
Depression had risen. The introduction of a local guideline for the management of depression 
in primary care could account for increased referrals. The 1993 Clinical Resource Audit
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Group (CRAG) issued a consensus statement on the recognition and management of 
depression. This suggested early use of antidepressant medication and referral for cognitive 
therapy for patients who posed any risk for self-harm, had more complex problems, or who 
presented with a chronic relapsing condition. In the case of anger, the introduction of group 
work targeting the treatment of anger occurring between 1996-98 might account for the 
increase in referrals.
Proportionate frequency with which Care Aims employed
Assessment was the Care Aim most frequently employed in Cohort Two. Its usage had risen 
significantly from 16.55 to 35.4%. Greater focus within the psychology service upon the 
assessment and formulation stage, in line with objectives set by the clinical effectiveness 
initiatives within the Ayrshire & Arran Trust could account for this. Significantly an 
Assessment Clinic initiative was commenced during Cohort Two which would also account 
for the increase in the reported use of this Care Aim. The increase observed could also have 
been due to inappropriate usage and reporting of the Care Aim. Use of Problem Resolution 
as a main Care Aim had decreased considerably in Cohort Two. The aim of restoring patients 
to their normal level of health or ability is ambitious (only appropriate for certain disorders), 
and increased familiarity with the core definition of this Care Aim may have resulted in more 
appropriate and limited usage in the second cohort.
Proportionate amount of Time employed by Reasons For Care and corresponding frequency 
of referral.
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PTSD employed the most time in face to face contact proportionately in Cohort One. 
According to the clinical psychologist’s impression of increasing complexity, there was an 
expectation that there would be an increase in the frequency of these referrals in Cohort Two. 
However, there was only a slight increase in referrals and no corresponding rise in time 
employed for this Reason For Care. The proportionate amount of time employed for PTSD’s 
has actually decreased by 8% over the two cohorts. This may have reflected a change in 
treatment approach by Psychologists. It should be noted that by the end of the 18 months, 
treatment remained incomplete in 35.6% of PTSD cases in Cohort Two. In Cohort Two 
OCD’s were notably employing more time in contact than any other Reasons For Care. This 
is not a surprising result, as OCD is a complex and chronic disorder, which we might expect 
to demand more time in contact.
According to the current evaluation, those referrals which were most demanding of time in 
Cohort One had not proved so in Cohort Two with the exception of Eating disorders and 
Relationship/ Social Problems. These had not increased considerably in terms of 
proportionate frequency of referral either. Those Reasons For Care most demanding of time 
in Cohort Two were not most frequently referred either. Therefore the impression that the 
proportion of Reasons For Care within the caseload which were very demanding of time was 
increasing has not been validated by this evaluation. However, 34.5% of all the cases seen 
were still in treatment, as were 38% of cases by the end of Cohort One. It cannot be inferred 
that these were cases that required longer-term therapy, as they may have been referred and 
seen at any point within the 18-month period. However this may have resulted in an 
underestimation of complexity in the caseload.
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A closer examination of the distribution of incomplete treatment episodes across Reasons For 
Care demonstrated that Relationship/Social problems and OCD, the Reasons For Care which 
employed most time in contact in Cohort Two have the highest proportion of incomplete 
cases. The limitation of only examining time data within an 18-month period may be the 
exclusion of the negative extremes of complexity, chronicity and severity, which would 
mediate more time in contact.
Whilst there was an increase in the absolute number of referrals in Cohort Two, there was a 
decrease in the mean number of time units employed overall in Cohort Two. The increase in 
number of psychologists from 16 WTE in Cohort One to 18 WTE and the additional skill 
mix of 2 Cognitive Behaviour therapists, and 1 counsellor could have been partly responsible 
for shorter time spent on cases, as introduction of skill mix can lead to more tailored and 
efficient interventions, requiring less time. Also during 1996-98 there was increased focus 
both nationally and locally on waiting times, with associated pressure on this service to 
increase throughput.
Whilst acknowledging the results of the current evaluation, the influence of certain factors in 
the interpretation of these results must also be considered. It was widely agreed that the two 
categories, which were combined to create the minimum data set i.e. Reason For Care and 
Care Aim, require further qualification. These parameters have not been subject to a 
validity/reliability study, therefore the inter-rater reliability o f psychologists in assigning 
Reasons For Care or choosing Care Aims cannot be determined. This has possibly been a 
major confounding factor within the current investigation and consequently there is a need to 
be circumspect in the appraisal of the results of the current evaluation. If  clinical audit is to
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be used to gain insight into caseload and case-mix and act as an effective influence on 
negotiating more meaningful contracts, it is vital to arrive at a coding system, which has a 
high degree of consensus, and is demonstrably reliable and valid for comparison across 
studies.
The results of the current evaluation highlight the fact that there is increasing demand for the 
psychology service. During Cohort Two the psychology service was able to absorb the 
increased rate of referrals and increase throughput in less time due to staff increases and by 
adopting a policy of minimal intervention. Robertshawe and Sheldon’s (1992) findings 
encapsulate the evaluation of Cohort Two. They reported that when a psychology service is 
working to capacity, it can only take on new referrals faster than it can discharge them if 
individual sessions are shorter, and the average number of sessions per individual is reduced. 
However, this is only feasible in the short term.
In a climate where clinical and cost effectiveness issues are paramount, psychology services 
need to investigate issues, which may influence caseload size and casemix. Evidence 
provided by The Psychotherapy Review (NHSE, 1996) suggests that certain psychological 
therapies work better for certain disorders. With some Reasons For Care, change requires 
long term maintenance and others are more amenable to shorter-term curative approaches. 
Service agreements for the provision of psychological services could consider head counts, 
proportions of specific Reasons For Care, and the provision of long or short-term therapies in 
order to be meaningful and prevent excessive demand, increased waiting lists, and neglect of 
other professional activities.
18
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Table 1 Absolute and proportionate frequency of referrals per Reason For Care
REASON FOR 
CARE
COHORT ONE 
(ongoing and new 
referrals 31/3/93 -  
31/10/95)
COHORT TWO 
(ongoing and new 
referrals 31/3/96 -  
31/10/98)
N =
% OF TOTAL 
REFERRALS N=
% OF TOTAL 
REFERRALS
Anxiety & Phobia 915 40.6 % 1252 30.1 %
PTSD 63 2.8 % 205 4.9 %
Anger 77 3.4 % 469 11.3%
Personality Disorder 25 1.1% 28 0.7 %
Depression 309 13.7% 885 21.3%
OCD 25 1.1% 50 1.2%
Behaviour/Movement 61 2.7% 76 1.8%
Addictions 149 6.6% 56 1.3%
Eating Disorder 33 1.5% 73 1.8%
Sleep Disorder 13 0.6 % 13 0.3%
Sexual Disorder 23 1.0% 46 1.1 %
Elimination 23 1.0% 43 1.0%
Relationship/Social 289 12.8% 624 15.0%
Dev’mental/ Speech 87 3.9% 213 5.1 %
Problems due to 
Physical Illness
118 5.2% 129 3.1 %
Other 45 2% 0 0
TOTAL 2255 100% 4162 100%
20
Table 2. Frequency and proportion of Care Aims employed across Reasons For Care in Cohort One 
and Cohort Two
CARE AIM COHORT ONE COHORT TWO
N= %
proportionate
frequency
N= %
proportionate
frequency
ASSESSMENT 372 16.5% 1474 35.4%
ENABLING 150 6.7% 592 14.2%
REHABILITATION 290 12.9% 629 15.1%
MAINTENANCE 58 2.6% 105 2.5%
SUPPORT 38 1.7% 265 6.4%
PROBLEM RESOLUTION 1318 58.5% 1088 26.1%
PALLIATIVE CARE 0 0% 1 0.02%
HEALTH PROMOTION 0 0% 8 0.2%
TOTAL 2226 100% 4162 100%
21
Table 3. Proportionate Time in Contact for Reasons For Care employing more time in 
Cohort One and Two.
Reasons For Care % time employed
Cohort One Cohort Two
PTSD 13.6 5.6
OCD 5.5 11.3
Relationship/social problems 10 10.8
Problems relating to physical 
illness
10.6 6.6
Behaviour/Movement
disorders
7.7 10.2
Eating disorders 8.5 8.9
Shaded cells represent those Reasons For Care employing proportionately more time in a particular 
Cohort.
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2. LITERATURE REVIEW
Psychological Adjustment to Cancer: The Relationship between 
Self-efficacy for coping, Dispositional Optimism and Depression -
A Review of the Literature.
Written in accordance with the guidelines for submission to Psycho-Oncology
(see Appendix 2.1)
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ABSTRACT
Self-efficacy for coping and dispositional optimism [DO] have been highlighted as possible 
determinants of adaptive coping in cancer. The extent to which these two factors influence or 
mediate depression in cancer patients is unknown. It has not been established if their effects 
are additive or independent. The aim of this review is to highlight the relationship o f self- 
efficacy and DO and depression in non-clinical samples and then focus on their role in 
psychological adjustment in cancer and how they achieve their effects. Electronic databases 
and review articles were searched for studies pertaining to the subject of this review.
High levels of self-efficacy protect individuals from dysphoria in reaction to stressors and 
DO acts as a stress buffer. Self-efficacy for coping in cancer has only been studied in one 
particular domain of coping (self-efficacy for cancer related symptoms) and was related to 
affective state. DO has been related to psychological adjustment in cancer via its effects on 
coping.
Research is required to establish if DO’s protective role in psychological adjustment will be 
altered if self-efficacy for coping with cancer is low and to investigate how self-efficacy for 
coping will relate to depression if there are no positive outcome expectancies due to low DO. 
It will also be important to study the relationship between particular efficacy beliefs for 
coping with all the major tasks faced by cancer patients and depressive symptomatology. 
Implications for psychological interventions for the treatment of depression in cancer 
patients will be discussed.
26
INTRODUCTION
Research on psychological aspects of cancer has become increasingly prevalent in the past 
few decades. Some advances have been made in describing the difficulties cancer patients 
face, and in examining the processes of adjustment (Anderson, 1989).
Recently two psychological factors have been highlighted as possible determinants of 
adaptive coping in cancer. Evidence from independent studies suggests that self-efficacy and 
Dispositional Optimism [DO] respectively influence psychological adjustment in response to 
negative life events or stressors in non-clinical samples (Carver and Gaines, 1984; Martin 
and Flett, 1996). Less attention has been paid to these constructs in relation to psychological 
adjustment to cancer, (Carver et al., 1993; Lev, 1997). The extent to which these two factors 
influence or mediate depression in cancer patients is unknown. It has not been established 
whether their effects are additive or independent on outcomes such as depression, as both 
have not been studied simultaneously specifically in relation to depression in cancer patients.
This review therefore aims to briefly highlight the relationship of self-efficacy and DO and 
depression in non-clinical samples and discuss how these variables achieve their effects. In 
turn, the review will focus on the impact of these factors on psychological adjustment in 
response to cancer, and models, which may elucidate their role. A subsidiary aim is to review 
the literature on illness representation [IR] in chronic illness and highlight it’s potential role 
in adjustment to cancer, as IR have never been studied in relation to depression in cancer. 
Further links and questions will also be generated which relate to treatment interventions for 
depression in cancer patients.
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Cancer
Cancer is a disease of cells proliferating with disregard to the body’s regulatory signals that 
causes tumours or neoplasms, which are either benign or malignant. Cancer is now the 
second leading cause of death in the UK (DoH, 2000). There are over 200 different types of 
cancer, but just four of them - lung, large bowel, breast and prostate account for half of all 
new cases and are responsible for over half o f all cancer mortality (Cartmell and Reed,
1995). Cancer affects every age group, although 50% of all cancer deaths occur in persons 
over 65 years of age. Studies indicate that cancer diagnoses have increased over the past five 
years with advances in early detection. (TSO, 1998; GRO for Scotland, 1998; and GRO for 
Northern Ireland, 1998).
Cancer and Depression
Cancer is associated with a host of enduring negative emotional responses, including anxiety 
and depression (Taylor and Aspinall, 1990; Mermelstein and Lesko, 1992; Barraclough, 
1994; McDaniels et al., 1995). Considerable evidence exists which suggests that depression 
is the most common disturbance secondary to cancer (McDaniels et al., 1995). The most 
comprehensive study of psychological morbidity in cancer to date was reported by Derogatis 
et al. (1983). They reported the prevalence of adjustment disorder with depressed or mixed 
emotional features to be 25% and a prevalence of major depression of 6% in their sample. 
More recent studies suggest considerable diversity in prevalence rates. Massie and Holland 
(1990) reported rates of at least 25% in a sample of hospitalised cancer patients. Ibbodson et 
al. (1996) controlled for disease and treatment factors and using a diagnostic clinical 
interview found 17% of the sample had a major depressive illness. Chocinov et al. (1994)
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found a combined prevalence rate for minor and major depression of 26% using Research 
Diagnostic Criteria and Endicott criteria.
Despite depression being such a widespread problem in cancer patients, it is estimated that 
20-25% of cancer patients suffer often unrecognised and untreated long-term depression 
(Bottomley, 1998). One explanation for this phenomenon is that depression is one of the 
most difficult psychological problems to identify. It is difficult to know when the “normal” 
sadness response to cancer becomes “abnormal”. Furthermore, treatment side-effects may 
confound the identification of depression. Taylor and Aspinall (1990) suggested that 
depression is undetected due to the common and misguided assumption that depression is a 
normal and inevitable reaction to threatening illness.
Depression is important not only for the distress it produces, but also because it may have an 
impact on long-term rehabilitation and recovery (Primeau, 1988). Depressed stroke patients 
have longer hospital stays (Cushman, 1986), show less motivation to undergo rehabilitation 
(Thompson et al., 1989), and are less likely to maintain the gains made during rehabilitation 
than non-depressed patients (Sinyor et al., 1986). Depressed Myocardial Infarction patients 
are also more likely to be rehospitalised (Stem et al., 1977).
Cancer and Coping
Cancer requires patients’ to call upon coping resources to meet each new challenge. Lazarus 
and Folkman (1984) defined coping as cognitive and behavioural efforts to manage demands 
appraised as taxing or exceeding resources. Significant numbers of people with cancer often 
experience substantial difficulties in coping with their illness (Greer, 1991). Research on 
coping with cancer indicates that active coping styles and perception of control are
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associated with more positive adjustment to the disease than coping styles characterised by 
avoidance (Dunkel-Schetter et al., 1992). Various types of coping strategies have been 
identified in cancer patients, which affect adjustment to cancer differently. Osowiecki and 
Compas (1999) examined relationships between coping, perceived control and symptoms of 
anxiety and depression in their longitudinal study of individual coping and adjustment to 
breast cancer. They found that Problem-Focused Engagement coping involved problem­
solving and cognitive restructuring and Emotion-Focused Engagement coping involved 
emotional expression and seeking social support, and both were associated with lower 
psychological distress when faced with cancer. However Problem-Focused Disengagement 
which was characterised by avoidance and wishful thinking and Emotion-Focused 
Disengagement coping which is characterised by social withdrawal and self-criticism were 
associated with higher emotional distress during adjustment to breast cancer.
Parle and Maguire (1995) explored relationships between cancer, coping and mental health. 
They highlighted that a major limitation of the research on coping process among cancer 
patients is the predominance of research on the relationships between coping responses and 
psychological outcomes. These designs have not adequately represented the complexity and 
diversity of demands associated with cancer and have neglected the role of appraisal in the 
assessment of the relationship between coping and mental health. Within Lazarus and 
Folkman’s model of coping, coping efforts are contingent upon the person’s appraisal of: (a) 
the degree of threat posed by the demand (primary appraisal); and the resources believed to 
be available to manage the demand (secondary appraisal). In preliminary results from a 
prospective study of affective disorders among cancer patients (Parle, Jones and Maguire,
1994), appraisal, coping responses, and coping-efficacy were all found to be significant 
predictors of subsequent affective disorders. Importantly patients who believed they could do
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nothing to manage the demands of cancer were at greater risk for subsequent affective 
disorder. Therefore examining the type of coping response in regard to secondary outcomes 
such as depression without regard to secondary appraisals such as self-efficacy beliefs is 
clearly not adequate.
Self- efficacy
The construct of self-efficacy was developed by Bandura in the 1970’s as a component of 
social learning theory. He defined perceived self-efficacy as people’s beliefs about their 
capabilities to produce designated levels of performance that exercise influence over events 
that affect their lives. The amount of effort expended, determination and affective response 
to accomplish a task depends on perceived self-efficacy (Bandura 1982, 1994).
Efficacy beliefs are thought to operate in concert with other socio-cognitive determinants in 
governing human adaptation and change. Perceived self-efficacy operates within a broad network of 
socio-cultural influences. Once formed, efficacy beliefs regulate aspirations (Bandura et al., 1997), 
choice of behavioural courses (Bandura, Adams, Beyer, 1977), mobilisation and maintenance of 
effort and affective reactions (Bandura, 1997). Efficacy beliefs are proposed as a major basis of 
action. People guide their lives by their beliefs of personal efficacy. Self-efficacy beliefs are thought 
to exercise influence over regulation of one’s own motivation (Bandura, 1988), thought processes 
(Bandura, 1989a), affective states, and actions. People’s beliefs in their efficacy have diverse effects. 
Such beliefs are believed to influence the courses of action people choose to pursue, how much effort 
they put into given endeavors, how long they will persevere in the face of obstacles and failures, their 
resilience to adversity, how much stress or depression they experience in coping with taxing 
environmental demands (Bandura, 1988c; Kavanagh, 1983), and the level of accomplishments they 
achieve. Efficacy is a generative capability in which cognitive, social, emotional and behavioural 
subskills must be organised and effectively orchestrated to serve innumerable purposes. There is a
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marked difference between processing subskills and being able to integrate them into appropriate 
courses of action and to execute them under difficult circumstances. Perceived self-efficacy is 
concerned not with the number of skills we have, but with what we believe we can do with what we 
have under a variety of circumstances.
The association between self-efficacy and depression in the general population is well 
established. (Rosenbaum and Hadari, 1985; Goozh and Maddux, 1992; Martin and Flett,
1996). Those with high perceived self-efficacy will approach tasks with a competitive sense 
towards mastery and positive self-esteem. In contrast low perceived self-efficacy is 
associated with incompetence, low self-esteem and depression (Bandura, 1994). Findings 
support Bandura’s (1977) hypotheses that depression will occur when either self-efficacy or 
outcome expectancy is low (Rosenbaum and Hadari, 1985; Goozh and Maddux, 1992; 
Martin and Flett, 1996).
High generalised self-efficacy (GSE) has predicted lower depression (Olioff, Bryson and 
Wadden, 1989). In theory this variable may have the capacity to buffer the effects of stress. 
Lightsey (1997) tested whether GSE, positive thoughts, optimism and self-mastery may act 
as stress buffers in response to negative life events. It was observed that when exposed to 
stressors, undergraduate students with higher GSE may be less dysphoric than persons with 
lower GSE, suggesting that GSE acts as a stress buffer. This may be due to a willingness to 
engage in active coping efforts, tenacity of coping efforts once initiated and success of 
coping efforts, thereby avoiding depression (Eden and Aviram, 1993)
Self-efficacy has a major impact on adjustment to chronic illness (Beckham et al., 1987, 
1994, 1995). Self-efficacy influences adjustment because it mediates the relationship
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between health related stressors and outcome variables. Increased self-efficacy in cancer 
patients is associated with decreased physical and psychological symptoms (Lev, 1997).
The role of self-efficacy in coping with cancer and adjustment has been highlighted by 
studies, which employed efficacy-enhancing interventions. Telch and Telch (1986) compared 
self-efficacy ratings of distressed individuals with cancer across three conditions, coping 
skills training treatment versus support group treatment versus no treatment control group. 
The coping skills training had boosted the cancer patients self-efficacy and in turn reduced 
distress and created better adjustment. Cunningham, Lockwood and Cunningham (1991) 
reported significant positive correlations between self-efficacy, mood and quality o f life and 
attributed improvement in these variables to a brief four-week intervention for self-efficacy.
Self-efficacy for coping with cancer is a slightly different construct from self-efficacy per se. 
It relates to expectations about coping with the major tasks that will confront cancer patients, 
even if the individual has not yet experienced the problem. It recognises that cancer does not 
represent a unitary variable and includes a broad range of demands (Dunkel Schetter et al., 
1992). The judgements of coping ability elicited are in response to these multiple demands 
and therefore provide far more reliable and meaningful measures of coping self-efficacy. 
These expectations are formed via assessment of their own internal resources as well as 
resources in their environment, which are processed and integrated and regulate their choice 
behaviour and effort accordingly. Parle and Maguire (1996) studied a construct similar to 
self-efficacy for coping in their study on maladaptive coping and affective disorders. In this 
examination of the effects of appraisals of threat, coping responses and resolution of 
concerns (coping-efficacy) on subsequent mental health; they highlighted the role of 
appraisal in secondary outcomes in cancer. Primary and secondary appraisals respectively
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relate to the degree of threat posed by the demand and the perception of ability to manage the 
threat posed by the demand. The degree of threat appraised, reporting of a helpless response 
and perceived success of primary responses in resolving concerns all predicted affective 
disorder. One limitation of this study was that it did not differentiate between primary and 
secondary appraisals in its analysis. However Parle and Maguire did posit that the helpless 
coping response was probably more appropriately understood as negative secondary 
appraisals (perceived ability to manage demands) which were predictive o f subsequent 
affective disorder.
Those patients who perceive themselves as capable of meeting the demands associated with 
cancer and it’s treatment will be able to mount resources to meet the many challenges they 
face (Grassi et al., 1993; Merluzzi and Martinez Sanchez, 1997). Lower ratings of perceived 
difficulty of coping behaviours by cancer patients were associated with more positive 
adaptation to cancer than their counterparts who held more realistic perspectives (Merluzzi 
and Martinez Sanchez, 1997).
During the development and validation of the Cancer Behaviour Inventory (CBI), a measure 
of self-efficacy for coping with all the major tasks in cancer, Merluzzi and Martinez Sanchez 
(1997) investigated the relationship between self-efficacy for coping, adjustment to illness, 
coping, DO and social support. They reported correlations between these factors and the 
CBI. Lev et al. (1999) found that both self-care self-efficacy (a person’s confidence to 
perform relevant self-care behaviours to promote health) and quality of life declined 
significantly with time. Their study also asserted that high self-care self-efficacy and 
adjustment are associated with improved coping, enjoyment and quality o f life. Self-care 
self-efficacy is therefore clearly differentiated from self-efficacy for coping as the latter
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relates to more holistic confidence to mount coping resources for the multiple demands 
associated with cancer and not simply geared to promoting health.
Theoretically self-efficacy operates as a mediating variable because it transforms or changes 
the relationship between two other variables (Baron and Kenny, 1986). Merluzzi and 
Martinez Sanchez (1998) propose a self-efficacy mediated model for coping with cancer and 
AIDS where a number of variables including the impact of disease and treatment on 
functioning, availability o f social support, coping style, personality characteristics, 
developmental stage and attitudes to disease affect outcomes such as psychological 
adjustment and quality of life through the mediation of self-efficacy. Many of these variables 
may also affect the outcome variables directly. The assumption of the model is that self- 
efficacy may mediate wholly or partially the effects of these predictor variables on outcomes.
The first study investigating the relationship between self-efficacy for coping with cancer 
and depression in an analysis was conducted by Beckham et al. (1997). They examined the 
relationship between self-efficacy for coping with cancer related symptoms such as pain, 
function, and patient cancer adjustment, depression, psychological distress and behavioural 
dysfunction in male cancer patients. They found that this domain of coping self-efficacy was 
related to all the adjustment measures, with the exception of depression, where the 
relationship failed to reach statistical significance. The design of the study did not permit the 
direction of the relationship between the variables to be determined. Crucially, this study was 
limited because it only looked at the self-efficacy for coping with cancer-related symptoms 
and not efficacy expectations across the domains of coping. This study could not reliably and 
meaningfully assess the relationship between the judgements of coping ability in response to 
the multiple demands of cancer and depression and adjustment. Simply focusing on one
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domain underestimates the demands to be met and coping resources needed. If the self- 
efficacy judgements relating to all the domains were appraised, the demands evaluated would 
increase substantially and a different relationship to depression may indeed be established.
Dispositional Optimism
Dispositional optimism [DO] is a variable that has been associated with depression in both 
the general population (Broomberger et al., 1996; Chang, 1998; Puskar et al., 1999) and in 
cancer patients (Epping-Jordan et al., 1999). DO, a stable personality characteristic, has been 
defined as the tendency to expect positive versus negative life outcomes (Scheier & Carver, 
1992). Regarding DO as a generalised expectancy for positive outcomes (Scheier & Carver,
1995) has important behavioural implications. This construct derives from a general model 
of behavioural self-regulation (Carver and Scheier 1981, 1982a and 1983) which suggests 
optimists are more likely to conclude impediments can be overcome. These beliefs and 
continued efforts to which they give rise should cause optimists to continue striving and deal 
with problems more successfully than pessimists. Empirical evidence for DO’s influence on 
self-regulation of behaviour is provided by Carver et al. (1979a). They demonstrated how 
chronic expectancies of being able to cope with a strong fear (of snakes) interacted with self­
focused attention to predict overt behaviour. Those individuals holding positive expectancies 
displayed increased self-attentiveness and enhanced effort to hold snakes.
This construct has widespread utility in the general domain of psychology because it posits 
that people’s actions are greatly influenced by their expectations about consequences o f those 
actions. Therefore DO is highly relevant to a variety of theories of motivated action (e.g., 
Bandura, 1977, 1986; Rotter, 1954; Seligman, 1975). People’s expectancies regarding 
outcomes are thought to act a major determinant of the choice between two general classes of
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behaviour: continued striving versus giving up and turning away. Paralleling this disjunction 
in behaviour is a disjunction in affect (Carver and Scheier, 1990a, 1990b). Favourable 
expectancies are proposed as giving rise to positive affect and vice-versa. Scheier and Carver
(1985) posit that global expectancies are relatively stable across time and context and they 
form the basis of an important characteristic of personality. Peterson and Bossio (1991) 
describe this cognitive construct as being related to the vigour and passivity with which 
individuals face the demands of life. One of the most prominent models of personality that 
incorporates measures of positive cognitions is the attributional style model (Peterson and 
Seligman, 1984). Optimistic attributional style was developed from the attributional 
reformulation of the learned helplessness model as a method of explaining individual 
differences in response to negative events (Abramson, Seligman and Teasdale, 1978). This 
model posits that the extent to which generalised expectancies are negative, internal and 
global, bad physical and mental health consequences will follow, a response style termed 
‘pessimistic explanatory style’.
DO plays a protective role in long-term psychological outcomes because it acts as an 
adaptational mechanism in the face of a wide variety of significant stressors. DO causes 
people to be more persistent and work harder at attaining goals. It facilitates generation of 
more effective sub-goals and more rapid initiation of strategies to manage problems sooner. 
A number of prospective studies have examined the effect of DO on subjective wellbeing 
when stressors are present. Carver and Gaines (1987) studied the development of post­
partum depression in women. They reported that optimism was associated with resistance to 
post natal depression and decreased the severity o f depression post delivery. Scheier, 
Weintraub & Carver, (1989) examined the influence of DO on the subjective reactions of a 
group of men over time to coronary artery bypass surgery. They observed that pre-surgically,
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optimists reported lower levels of hostility and depression than pessimists. In the week 
following the operation, optimists reported feeling greater relief and happiness. Also 
optimists reported much more favourable quality of life at 6-months follow up than 
pessimists.
Research studies have investigated the potential mechanisms by which DO confers positive 
benefits on physical and psychological wellbeing and how it may mediate psychological 
distress. It may be the manner in which optimists and pessimists cope with stress that is the 
mediator of such effects. Scheier, Weintraub & Carver (1985) presented their subjects with a 
hypothetical event involving a high degree of stress and asked them to imagine their 
response. Analysis demonstrated that the optimists and pessimists spontaneously employed 
different coping strategies. Optimism was highly correlated with active coping, complexity 
of coping strategies and inversely correlated with focusing on emotion, emotional 
expression, and disengagement from goals. In a similar study Scheier, Weintraub & Carver
(1986) found optimism was positively correlated with problem-focused coping in a sample of 
undergraduates recalling stressful events and their responses.
Coping differences in optimists and pessimists may well underlie the effects of optimism on 
psychological and physical wellbeing. In their college adaptational study, Taylor and 
Aspinall (1990) reported that the beneficial effects of optimism operated at least in part 
through differences in coping. Optimism may serve as a critical coping resource by 
promoting active problem-focused coping and by reducing the perceived magnitude of the 
threat.
DO has a demonstrable impact on cancer patients’ emotional functioning. Pozo et al. (1990) 
reported that optimism predicted distress over time in a prospective study of psychological
38
adaptation of women to surgery for early stage breast cancer. Carver et al. (1993) found that 
differences in coping serve as a mediating mechanism by which differences in optimism 
influence subjective wellbeing in women with early stage breast cancer. Three reactions were 
particularly prominent as mediators: acceptance, denial and behavioural disengagement. 
These three reactions served as mediating routes through which optimism was related to 
distress. Epping Jordan et al.’s (1999) study investigated whether there are background 
dispositional factors that specifically predict anxiety and depression in women with newly 
diagnosed breast cancer. They also investigated change in these processes across time. They 
also examined whether the relationship of background dispositional factors such as age, 
cancer stage, education, DO and anxiety and depression was direct or mediated by proximal 
variables such as intrusive thoughts, avoidance, problem-focused engagement and 
disengagement and emotion-focused engagement and disengagement coping. They found 
that the background dispositional factor of DO had a direct relationship to anxiety and 
depression symptoms at diagnosis and six-month follow-up. However at diagnosis and six- 
months, high DO also predicted the proximal variable of greater emotion-focused 
disengagement coping, which in turn predicted higher anxiety and depression symptoms. 
Therefore DO predicted anxiety and depression directly and was partially mediated via 
emotion-focused disengagement coping.
Illness Representation [IR]
Patient’s cognitive representations of illness and coping behaviours are viewed as 
particularly important determinants of adaptive coping outcome in chronic illness (Meyer et 
al., 1985; Petrie and Weinman, 1997). Upon symptom appearance, diagnosis or during the 
illness experience, individuals construct a representation of their health threat, which
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influences their behaviour. Leventhal et al’s., (1980) self regulation model links IR and 
coping behaviour to adaptive outcomes. According to this model people create cognitive 
models o f their representations of illness to guide coping and via coping influence adaptive 
outcomes such as mood and disability. Leventhal and Nerenz (1983) identified five 
dimensions of this IR in terms of which most people think of their disease. These are 
identity, cause, consequences, time-line and curability. Weinman et al. (1996) developed the 
Illness Perception Questionnaire (IPQ), in an attempt to try and understand the nature of 
illness related coping.
Little data are available on the association between IR’s and adjustment among cancer 
patients. Buick (1997) examined IR of breast cancer patients coping with radiotherapy and 
chemotherapy and the process of change in IR among these patients. Buick reported that 
negative illness beliefs were associated with maladaptive psychological responses. It was 
also observed that schema composed of more moderate or positive illness perceptions 
contrasted with effects on psychological adjustment with schema composed of the negative 
dimensions of cancer, as negative perceptions foster-emotion focused and disengagement 
style coping that results in patients being unable to control the disruption to their life during 
the course of their illness.
The research on IR to date has neglected the investigation of the association of IR and 
depression in cancer patients. Moss-Morris et al. (1996) studied variables relevant to 
depression in chronic fatigue syndrome (CFS). Non-depressed CFS patients held IR 
characterised by illness identities incorporating a broad range of symptoms. Beliefs about 
chronicity and consequences were generally negative. Lack of personal responsibility and 
external attributional style protected their self-esteem. In contrast CFS patients with
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concurrent depression had the most pessimistic illness beliefs and internal, uncontrollable 
attributions leading to more helpless illness attributions and lower self-esteem.
Problems with the Research
Many studies are limited by a cross-sectional design, which precludes establishing causality. 
A cross-sectional design also typically involves measurement at one point in time. This 
might not yield meaningful measures for less constant variables, such as coping style and 
self-efficacy, which are not by nature static, as they change according to the demands of the 
disease and according to our stress appraisals. Longitudinal prospective studies would 
therefore be more appropriate for systematic investigations involving these variables. 
Exclusive use of self-report measures to determine coping style and effort is problematic, as 
the degree to which they reflect actual behaviour is unsubstantiated. Observational studies 
are needed to validate self-report coping inventories.
Research on the coping process among cancer patients has predominantly investigated the 
relationships between coping responses and psychological outcomes. In these largely cross- 
sectional studies, self-report instruments have been used to measure the frequency of a 
limited range of coping responses in relation to any recent stressful situation, which may or 
may not be relevant to cancer. The shortcomings of this methodology include the lack of 
attention given to specific characteristics of cancer as the psychological stressor, and the 
omission of other coping process variables including appraisals and coping-efficacy. A more 
rigorous approach to measurement of coping variables involves the use of semi-structured 
interviews (Parle and Maguire, 1995; 1996).
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Few if any studies mentioned in the review investigating the role of cognitive constructs in 
relation to depression in cancer patients actually sample cancer patients diagnosed with 
depression. Elevated scores on self-report measures such as the Beck Depression Inventory 
(BDI; Beck et a l, 1961) and Hospital Anxiety and Depression Scale (HADS; Zigmond & 
Snaith 1983) indicate dysphoria rather than nosologic depression. Most studies also look at 
somewhat diluted indices of depression, such as psychological distress, helplessness and 
hopelessness, combined anxiogenic and depressive symptomatology in the form of ratings of 
affective/emotional distress (Epping Jordan et al., 1999). Therefore we cannot assume that 
the results generalise to clinically depressed patients (Kendall et al., 1987).
Summary and Conclusion
The construct of self-efficacy has been associated with depression in the general population 
and in the cancer population (Lightsey, 1997; Lev et al. 1997). As yet in the cancer literature, 
self-efficacy for coping with cancer symptoms has been the only behaviour-specific efficacy 
expectation to be directly linked to affective state (Beckham et al., 1997). The relationship 
between particular efficacy beliefs for coping with all the major tasks faced by cancer 
patients and depressive symptomatology has yet to be studied.
Prospective studies examining DO’s influence on subjective wellbeing in the presence of 
stressors demonstrate that DO acts as a stress buffer (Carver and Gaines, 1987; Scheier, 
Weintraub and Carver, 1989). Carver et al. (1993) and Epping-Jordan et al. (1999) 
demonstrated that optimism is psychologically adaptive and related to overall adjustment in 
breast cancer patients via its effects on coping.
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The constructs of self-efficacy for coping and DO have not been studied together in relation 
to depression in cancer patients. The importance of studying DO’s relationship to depression 
in cancer patients alongside self-efficacy for coping is emphasised by the possibility of an 
intrinsic change in DO’s protective role in psychological adjustment in cancer directly and 
via coping strategies if self-efficacy expectations for coping are low. Judgements of little or 
no ability to mount coping resources to meet the demands of cancer will obviously influence 
the initiation and use of the coping strategies, which mediate DO’s protective role. The 
converse position is also intriguing in relation to psychological adjustment in cancer patients. 
If patients have high self-efficacy for coping with the demands of cancer, but low DO, then 
judgements supporting the ability to cope may not have any influence on coping behaviour. 
Without generalised expectancy for positive outcomes as proposed by Scheier and Carver 
(1995) patients may not continue to strive to deal with problems related to cancer and initiate 
active and complex coping strategies.
Knowledge of the factors associated with adjustment to cancer may be used in several ways. 
The literature suggests that self-efficacy for coping and DO are useful markers which can 
help to identify those at risk of developing depression. Increased knowledge of the risk 
factors for depression should be able to lead on to targeted intervention studies. Knowledge 
of IR may also provide some indication of the level of psychological and functional 
adaptation patients maybe able to achieve and therefore aid the development of interventions 
to facilitate self-management of cancer.
This study has clinical implications, because self-efficacy is not a static characteristic, in 
theory it can be altered by behaviour, and learned. The CBI assesses efficacy expectations for 
particular domains of coping, if certain domains are more relevant to depression, then
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efficacy-enhancing interventions can be tailored specifically to address efficacy in these 
areas and protect against development of depression, or ameliorate existing depression. DO 
is an internal resource, which may be subject to influence through coping skills training. 
Recent studies aimed at reducing depression and psychological distress in chronic illness 
have used optimism-training techniques and observed that changes in beliefs and 
expectations relating to optimism protect against depression (Riskind et al., 1996; Seligman, 
1998).
This review has established that self-efficacy for coping with cancer and DO are important 
determinants of psychological adjustment both directly and through their relationship with 
coping. Further study is required to investigate their interrelationship with depression in 
cancer patients.
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3. MAJOR RESEARCH PROJECT PROPOSAL
Depression in Cancer Patients: An Examination of the Role of Self- 
Efficacy for Coping with Cancer and Dispositional Optimism.
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Summary
Considerable evidence exists about the prevalence of affective disorders in patients with 
cancer. The purpose of this study is to examine the influence of self-efficacy for coping with 
cancer and dispositional optimism [DO] on depressive symptomotology. Whilst self-efficacy 
for coping with cancer symptoms has been linked with affective state, there has been little 
exploration of how self-efficacy for coping with cancer will relate to depressive dysfunction 
in cancer patients. DO is a recognised predictor of psychological distress in a cancer 
population, and is also a recognised source of efficacy information, however it’s protective 
role in adjustment is untested in the presence of self-efficacy for coping with cancer.
The study will test the hypothesis that depressive pathology will be related to low levels of 
self-efficacy and DO, and it will examine the interaction between self-efficacy for coping 
with cancer and DO. This study will also address the question of whether DO will act as a 
moderator variable both in efficacy expectations and in depressive symptomotology.
Patients attending the Beatson Oncology service or medical departments of the Western 
Infirmary will be recruited and complete self-report measures of these variables, t-tests and 
analyses of variance will examine the relationship between the variables and severity of 
depression. Obtained data may have implications for determining sources of difficulty in the 
adjustment process, allowing more tailored interventions, whilst also promoting self­
regulation.
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Introduction 
Depression and cancer
Cancer is associated with a host of negative emotional responses, including anxiety and 
depression (Taylor and Aspinall, 1990). Considerable evidence exists which suggests that 
depression is the most common disturbance secondary to cancer (McDaniels et al., 1995). 
Derogatis et al. (1983) reported that in a sample of 215 randomly selected outpatients with 
cancer, 13% of those with a DSM III diagnosis (47%) had depression. More recent studies 
suggest considerable diversity in prevalence rates. Kathol et al. (1990) and Middlebroe et al. 
(1994) reported major depression rates of 30% and 10% of their samples respectively.
Self- efficacy
Self-efficacy has demonstrable relevance for adjustment in patients’ with chronic medical 
conditions. It has been defined as an individual’s judgement of their capabilities to execute 
given levels of performance and to exercise control over events (Bandura, 1987). It appears 
that when self-efficacy or outcome expectancy is low people can be vulnerable to depression 
(Bandura, 1977).
Increased self-efficacy in cancer patients is associated with decreased physical and 
psychological symptoms (Lev, 1997). Self-efficacy for coping with cancer is a slightly 
different construct from self-efficacy per se. It relates to expectations about coping with the 
major tasks that will confront cancer patients, even if the individual has not yet experienced 
the problem. According to Bandura (1991b), those with high efficacy expectations for coping 
feel that they are able to call upon reserves to meet the challenges involved in coping with
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stressors such as cancer. Those who are low in efficacy may feel overwhelmed by the 
demands of their situation.
Beckham et al. (1997) looked at the relationship between self-efficacy for coping with cancer 
related symptoms and patient cancer adjustment, depression, psychological distress and 
behavioural dysfunction in male veteran cancer patients. They found that coping self-efficacy 
was related to all the adjustment measures, with the exception of depression, where the 
relationship failed to reach statistical significance.
According to Merluzzi and Martinez Sanchez (1997), who recently developed a 
comprehensive measure of efficacy for coping with all the major tasks in cancer, efficacy 
expectations play a major role in coping. This belief is based on Bandura’s hypotheses 
regarding self-efficacy as an integral part of a general self-regulation model, which plays a 
major role in the self-observations, judgement processes and self-reactions forming the three 
domains of self-regulation. Merluzzi and Martinez Sanchez found that this measure which 
taps the major domains of coping is significantly related to variables related to adjustment to 
cancer. One of these variables was optimism, which the authors believed was a source of 
efficacy information.
Dispositional Optimism
Dispositional optimism [DO] is a variable that has been associated with depression in both 
the general population (Puskar et al., 1999; Chang, 1998; Broomberger et al., 1996) and in 
cancer patients. DO, a stable personality characteristic, has been defined as the tendency to 
expect positive versus negative life outcomes (Scheier and Carver, 1992). DO plays a 
protective role in long-term psychological outcomes because it acts as an adaptational
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mechanism in the face of a wide variety of significant stressors. Optimists report better 
psychological adjustment to negative life events (Scheier, Weintraub & Carver, 1986) and to 
serious illnesses including cancer (Carver et al., 1993).
DO also seems to be an important prospective predictor of distress for individuals with life 
threatening illness (Carver et al, 1994). In their study of women with early stage breast 
cancer it was suggested that DO may be a predisposing marker for vulnerability to 
adjustment difficulties. The findings of Curbow et al. (1993) and Miller et al. (1996) 
reinforce this suggestion. Most recently in a study on psychological processes in breast 
cancer patients Epping Jordan et al. (1999) reported a direct relationship between DO and 
anxiety and depressive symptoms both at the time of diagnosis and at 6 months post 
diagnosis. DO acted as a significant predictor of emotional distress and more optimistic 
women experienced lower levels of distress. The interpretation of these results is limited by 
the absence of a control group, therefore it remains to be seen how this personality variable is 
associated with depression per se amongst cancer patients.
Self-efficacy as a general construct has been associated with depression in the general 
population and in the cancer population. As yet in the cancer literature, self-efficacy for 
coping with cancer symptoms has been the only behaviour-specific efficacy expectations to 
be directly linked to affective state (Beckham et al., 1997). The relationship between 
particular efficacy beliefs for coping with all the major tasks faced by cancer patients and 
depressive symptomotology has yet to be studied. Additionally the potential links between 
self-efficacy for coping with cancer and DO have not yet been studied, either together or 
directly in relation to depressive symptomotology. Merluzzi and Martinez Sanchez (1994) 
found that efficacy expectations on all the factors of the Cancer Behaviour Inventory were
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highly correlated with optimism. Current knowledge on DO posits that it plays a protective 
role in cancer, in that it acts as a buffer to stress by influencing the types of coping strategies 
chosen. DO is positively associated with active problem-focused strategies, such as 
acceptance, positive re-appraisal and seeking social support (Carver et al., 1994). However 
the role of DO in protecting cancer patients from depression is largely untested if a variable 
such as self-efficacy for coping with cancer is introduced into the analysis.
It has been increasingly acknowledged that illness representation [IR] is a psychological 
variable that plays a role in adjustment to chronic illness, however due to the dearth of 
research on IR in the cancer population, there is no specific knowledge about the relationship 
of IR to depression. Hence a subsidiary aim of this study will be to describe the IR’s of the 
sample.
The purpose of this study therefore is to examine the relationship of self-efficacy for coping 
with cancer and dispositional optimism to depression among cancer patients. Additionally 
the relationship between self-efficacy for coping with cancer and DO will be examined.
Aims
1. To examine the impact of self-efficacy for coping with cancer on depressive 
symptomotology.
2. To examine the relationship between DO and self-efficacy beliefs for coping with 
cancer.
3. To examine the relationship between DO and depressive symptomotology.
4. To describe the illness representations of the sample.
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Hypotheses
1. It is hypothesised that higher levels of DO will be associated with lower levels of 
depressive symptomotology.
2. It is hypothesised that low efficacy expectations will be associated with less depressive 
symptoms in patients with high DO than low DO.
3. It is hypothesised that lower self-efficacy for coping with cancer will be associated with 
higher levels of depressive symptomotology.
Participants
Participants will be recruited from the Beatson Oncology Centre and other medical 
departments of the Western Infirmary in Glasgow. Participants will be included if they have 
a confirmed diagnosis of, breast cancer, colorectal cancer or leukaemia, as these are the most 
commonly occurring cancers with good prognoses. The sample will be restricted to those 
recently diagnosed because it has been shown that patients’ adjustment to cancer may vary 
over time (Anderson et al., 1989). In regards to participant’s cancer stage, the recruitment 
strategy will aim to sample equally among those with stage I, II and III cancers. Participant’s 
cancer stage and disease status will be classified according to the nomenclature of the 
American Joint Committee on Cancer (1992): localised disease refers to stages 1 and 2, 
regional disease refers to stage 3 and metastatic/systemic disease refers to stage 4. 
Participants with a diagnosis of leukaemia will be classified according to the French- 
American classification (FAB). Experimental control will be addressed by matching subjects 
in the depressed and non-depressed group by age, gender, site of cancer, and stage of disease.
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Participants Common Inclusion Criteria for Both Groups
- Aged between 16-65 years.
Recent diagnosis of cancer (approximately 0-12 weeks)
- All participants diagnosed with stages 1, 2 (localised disease), or 3 (regional disease).
All participants diagnosed with breast, colorectal cancer or leukaemia.
Participants Common Exclusion Criteria for Both Groups
Impaired cognitive ability -  demonstrating evidence of dementia or acute confusional 
state. ( will be assessed via clinician judgement)
Additional Inclusion Criteria for the Depressed Group
Those who obtain a score of >11 on the Hospital Anxiety and Depression Scale (HADS) 
depression subscale and an index of >50 on the Zung Self-rating Depression Scale 
(ZSDS) ( See Measures Section)
Additional Inclusion Criteria for the Non-depressed Group
Those who obtain a score which is <10 on the HADS depression subscale and <50 on the 
ZSDS
Measures
The following questionnaires will be used in the study: -
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Cancer Behavior Inventory Version 2.0 (CBI-L 2.0: Merluzzi and Martinez Sanchez, 
1997) -  The CBI is a measure of self-efficacy for coping with cancer. The 33 item long form 
(CBI-L version 2.0), revised in 1999 was used in the current study. Items are rated on a nine- 
point Likert Scale from “not at all confident” to “totally confident”. The CBI-L has a seven 
factor structure which accounts for 63% of the variance. Theses factors are Maintenance of 
Activity and Independence, Seeking and Understanding Medical Information, Stress 
management, Coping with Treatment Related Side-Effects, Accepting Cancer/Maintaining a 
Positive Attitude, Affective Regulation and Seeking Support. In validation studies (Merluzzi, 
Martinez Sanchez and Nairn, 1997) computed internal consistency of the original CBI as a  = 
.94 (see appendix 3.1)
Life Orientation Test (LOT; Scheier & Carver 1985; Scheier, Carver & Bridges 1994) -  
The LOT is a measure of dispositional optimism. The LOT is a 12 item self-report scale. 
Items are rated on a 5-point Likert Scale from “strongly disagree” to “strongly agree”. In 
validation studies (Scheier et al., 1994) internal consistency was a  = .78 (see appendix 3.2)
Illness Perception Questionnaire (IPQ; Weinman, Petrie, Moss-Morris & Home, 1996) -  
This questionnaire has been developed to assess the cognitive representations of illness. It 
comprises of five scales providing information on the five dimensions underlying the 
cognitive representation of illness. These are Identity, Time-Line, Consequences, Control 
and Cause (see appendix 3.3)
Hospital Anxiety and Depression Scale (HADS; Zigmond & Snaith 1983) -  The HADS is 
a 14 item self-report scale, which was developed specifically for the measurement of 
depression and anxiety in physically ill populations. The subscale scores of depression and 
anxiety have been validated in cancer patients (Ravasi et al. 1990; Moorey et al., 1991).
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Zung self-rating depression scale (ZSDS) (Zung, 1965) is a 20 item scale involving ratings 
on a four-point qualitative temporal scale (“a little of the time”, “some of the time”, “good 
part of the time”, and “most of the time”). Items are scored 1,2,3 and 4 respectively, with 
higher scores indicating more depression. The Zung rating scale has recently been used 
successfully as a screening tool for depression in a cancer population. Internal consistency 
was calculated as a  = 0.84 (Dugan et al., 1998). Reynolds and Gould (1981) reported a 
correlation of +0.57 with the BDI.
It is believed that by utilising two measures of depressed symptoms, the accuracy of 
determining the presence or absence of clinically significant depressive symptoms will be 
increased.
Sociodemographic factors, including age, gender, marital status, and employment status were 
elicited via questionnaire. Cancer site and stage of disease and treatment information will be 
recorded from the participant’s medical records.
Endpoints of Study
Primary Endpoint
Dispositional optimism in patients with depression versus no depression
The life Orientation Test (LOT) score will be compared by t-test between the Depressed 
group and Non-Depressed group. A difference in LOT of 5 points would be considered to be 
clinically significant. With 16 subjects in each group, the study will have 80% power to 
detect a difference of 5 points at alpha 0.05.
Secondary Endpoint
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Self-efficacy for coping with cancer in patients with depression versus no depression
The Cancer Behaviour Inventory (CBI) score will be compared by t-test between the 
Depressed Group and Non-Depressed Group. A difference in CBI-L scores of 40 points 
would be considered to be clinically significant. With 16 subjects in each group, the study 
will have 80% power to detect a difference of 40 points at alpha = 0.05.
The interaction between dispositional optimism and self-efficacy
The interaction between high and low dispositional optimism (median split in scores on 
LOT) and high and low self-efficacy ratings (median split in scores on the CBI-L) will be 
examined on depressive symptoms using ANOVA. With 10 subjects for each combination 
(high DO/high SE; high DO/low SE; low DO/high SE; low DO/low SE). The study will have 
80% power to detect a difference on the HAD depression scale score of 3 (using data from 
Moorey et al., 1991).
Design and Procedure
A variety of recruitment methods will be employed to secure an appropriate sample o f cancer 
patients with varying degrees of depressive symptomotology. These will include leaflet 
advertising for people who have developed depressive symptoms since a cancer diagnosis 
and via referral by the oncologists. Tara Wyne (Trainee Clinical Psychologist) will interview 
all potential participants, who will be matched according to age, gender, tumour site, and 
stage of disease to identify if any depressive symptoms are evident and screen for any 
exclusion criteria.
The nature and procedure of the study will be explained to suitable participants and an 
information sheet provided (see appendix 3.4). Those patients willing to be involved will be 
asked to sign a consent form (see appendix 3.5) indicating this and will also have the 
opportunity to ask questions. The participant will then be asked to complete the HADS, 
ZSDS, IPQ, CBI-L and the LOT. It is anticipated that completion of the above measures 
should require no longer than 1 hour. Should any of the scores on the HADS or ZSDS reach 
“caseness” criterion this will be discussed with the patient and depending on consent, the 
appropriate consultant will be notified and recommendations made for management.
Settings and Equipment
Facilities at the Department of Psychological Medicine, Gartnavel Royal Hospital will be 
used in the production of the questionnaires and other administrative materials. Information 
processing and data analysis facilities such as SSPS will also be available at the Department 
of Psychological Medicine. It is anticipated that some assistance might be required from staff 
at the BOC in order to facilitate access to a sample of appropriate patients and to procure a 
room for interview purposes and gain access to medical records to verify cancer site and 
stage of disease of participants.
Data Analysis
Data from the questionnaires will be entered anonymously onto a SSPS database in order to 
be analysed. Descriptive statistics will initially be conducted for the purposes of sample 
description. Inferential analyses will be paired sample t-tests to analyse the difference in 
scores on the main measures (chosen for parametric/nonparametric as appropriate). These 
tests are being employed because it is believed that a two-group design will more powerfully
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test the hypothesis. Anovas may be used to examine the interaction of high and low self- 
efficacy and high and low DO and the subsequent effect on severity of depressive 
symptomotology.
Practical Applications
This study has important implications for determining what factors are determinants of 
adjustment to cancer, and to pinpoint which elements of self-efficacy and levels o f DO are 
particularly related to specific instances of dysfunction. If we can determine that low levels 
of efficacy for the major domains of coping are related to symptoms of depression then 
interventions can be far more specific and tailored to individuals. Another application of this 
study may be to allow clinicians to intervene in the adjustment process to avoid the 
development of more enduring problems like depression. Other practical applications include 
individuals with cancer becoming more aware of their specific self-efficacy appraisals, and 
how these relate to their progress in practical and psychological terms. Increased awareness 
of the protective role of DO might also provide them with insight into internal resources 
which can be used to counteract maladaptive adjustment in the form of depression, therefore 
allowing them to self-regulate or seek out services sooner.
Ethical Approval
Ethical approval for this study was gained from the West Ethics Committee for the North of Glasgow 
University Hospital Trust (see appendix 3.6).
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AMENDMENTS TO PROPOSAL
The following statement explains the discrepancies between the major research project 
proposal and the major research project paper.
The inclusion criterion for the participants of the study referring to time since diagnosis was 
changed from zero to three months to zero to six months. Due to time limitations and 
recruitment issues this time period was widened. The initial reasoning for restricting it to 
three months was because it has been established that adjustment to cancer changes over 
time. However the authors of the CBI (self-efficacy for coping variable) state that time since 
diagnosis does not affect judgements of self-efficacy. The LOT measuring the second 
variable of interest is a dispositional resource and would be unaffected by time since 
diagnosis.
The cancer types to be included in the sample were initially breast, colorectal and leukaemia 
as they were commonly occurring. However due to time limitations it was decided that a 
heterogeneous sample inclusive of various cancer types would be acceptable.
The planned statistical analysis was altered following consultation with Dr Janies Currall (medical 
statistician). There were unequal cell sizes in the ANOVA, which examined the interaction between 
high and low DO, and high and low self-efficacy ratings on depressive symptoms, therefore 
indicating cautious interpretation of any results. Examination of the full range of scores on the 
continuous variables of self-efficacy for coping and DO and their relationship to depression was 
carried out using a multiple regression analysis to permit further clarification of the relationship 
between these variables and permit important comparisons to be made with prior studies.
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Depression in Cancer Patients: An Examination of the Role of Self- 
Efficacy for Coping with Cancer and Dispositional Optimism.
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ABSTRACT
The relationship between self-efficacy for coping with cancer, dispositional optimism [DO] 
and depression was studied in 37 cancer patients recruited from a specialist cancer centre and 
from a haematology ward in a local general hospital. Participants completed the Cancer 
Behavior Inventory (CBI), Life Orientation Test (LOT), Illness Perception Questionnaire 
(IPQ), the Hospital Anxiety and Depression scale (HADS) and the Zung Depression Rating 
Scale (ZSDS). Consistent with the hypotheses, DO and self-efficacy for coping with cancer 
were lower in the depressed group. Correlational analyses indicated that depression was 
positively associated with all the domains of coping on the CBI. A median split on CBI and 
LOT scores allowed analysis of the interaction between high and low DO and self-efficacy 
for coping on depressive symptoms. A main effect for self-efficacy for coping was noted. 
Regression analyses revealed that self-efficacy for coping accounted for 48% of the variance 
in total depression scores on the HAD. The results of the analyses suggested that contrary to 
expectation, DO did not compensate for low self-efficacy and protect against depression. 
Self-efficacy for coping assumed this protective role irrespective of the level of DO. There 
may have been conceptual overlap between the two constructs and situation specific outcome 
expectancies may have influenced responses on the DO measure that could have confounded 
DO’s relationship to depression. Findings are discussed within the context of the current 
literature and implications for future research are proposed.
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INTRODUCTION 
Cancer and Depression
Cancer is now the second leading cause of death in the UK (DoH, 2000). Lung, large bowel, 
breast and prostate cancer account for half o f all new cases and are responsible for over half 
of all cancer mortality. Patients with cancer experience considerable stress, which can have 
prolonged psychological consequences. Research has hypothesised that cancer, like other 
serious and often chronic illnesses, is associated with a wide range o f responses, of which 
depression is the most common (Mermelstein and Lesko, 1992; McDaniels et al., 1995). 
Derogatis et al. (1983) found a prevalence of adjustment disorder with depressed or mixed 
emotional features to be 25% and a prevalence of major depression to be 6%. More recent 
studies suggest considerable diversity in prevalence rates. Ibbotson et al. (1996) controlled 
for disease and treatment factors and using a diagnostic clinical interview found 17% of the 
sample had a major depressive illness. Chocinov et al. (1994) found a combined prevalence 
rate for minor and major depression of 26% using Research Diagnostic Criteria and Endicott 
criteria.
The wide variation in these studies reflects different settings, disease sites and stages, and the 
use of different research instruments, cut off scores and diagnostic criterion. Despite 
evidence of high levels of depression in cancer patients, under diagnosis and under treatment 
of depression continues to be common. Bottomley (1998) estimated that 20-25% of cancer 
patients are in this position. One explanation may be the common and misguided assumption 
that depression is a normal and inevitable reaction to life threatening illness (Taylor and 
Aspinwall, 1990).
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Psychological Factors
Given the prevalence of depression among individuals with cancer, it is important to identify 
potentially modifiable contributing psychological factors. Three of these factors may be self- 
efficacy for coping with cancer, dispositional optimism [DO] and illness representation [IR].
Self- Efficacy
Self-efficacy has a major impact on adjustment to chronic illness (Beckham et al., 1987, 
1994, 1995). Bandura (1982, 1994) defined perceived self-efficacy as people’s beliefs about 
their capabilities to produce designated levels of performance to exercise influence over 
events that affect their lives. Self-efficacy influences adjustment because it mediates the 
relationship between health-related stressors and outcome variables (Beck and Lund, 1981). 
Beckham et al. (1994) reported that self-efficacy was a consistent predictor of adaptational 
reactions in Rheumatoid Arthritis and that patients with higher self-efficacy were less 
affected by depression. Parle and Maguire (1995, 1996) highlighted the role of appraisal in 
secondary outcomes in cancer in their study on maladaptive coping and affective disorders. 
They defined primary and secondary appraisals respectively as the degree of threat posed by 
the demand and the perception of ability to manage the threat posed by the demand. They 
reported that the degree of threat appraised and reports of a helpless response predicted 
affective disorder. They posited that the helpless coping response was probably more 
appropriately understood as negative secondary appraisals (negative perception of ability to 
manage demands). Therefore indicating that a construct similar to self-efficacy was a 
predictor variable in affective disorder through its relationship to coping.
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Self-efficacy for coping with cancer is a slightly different construct from self-efficacy per se. 
It recognises that cancer does not represent a unitary variable and includes a broad range of 
demands (Dunkel Schetter et al., 1992). It relates to expectations about the ability to mount 
coping resources to meet the demands of the major tasks that will confront cancer patients. 
These expectations are formed via assessment of internal and external resources, which are 
then processed, and choice behaviour and effort regulated accordingly. Those patients who 
perceive themselves as capable of meeting the demands associated with cancer and it’s 
treatment will be able to mount resources to meet the many challenges they face (Grassi et 
al., 1993; Merluzzi and Martinez Sanchez, 1997). Lower ratings of perceived difficulty of 
coping behaviours by cancer patients were associated with more positive adaptation to cancer 
than their counterparts who held more realistic perspectives (Merluzzi and Martinez Sanchez, 
1997).
Beckham et al. (1997) examined the relationship between self-efficacy for coping with 
cancer-related symptoms such as pain and function, and patient cancer adjustment, 
depression, psychological distress and behavioural dysfunction. Self-efficacy for coping was 
related to all the adjustment measures, with the exception of depression. However this study 
was limited because it only looked at self-efficacy for coping with cancer related symptoms 
and not efficacy expectations across other domains of coping. If all the domains of coping 
were appraised, the demands evaluated might increase substantially and a different 
relationship to depression may indeed be established.
Therefore the extent to which self-efficacy expectations for coping with the demands of 
cancer and depression are related has yet to be investigated. If specific domains o f coping
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were highlighted as problematic, efficacy enhancing interventions using coping skills 
training could be tailored and prevent depression.
Dispositional Optimism [DO]
DO has been defined as the tendency to expect positive versus negative life outcomes 
(Scheier and Carver, 1992). These generalised positive outcome expectancies play a 
protective role in long-term psychological outcomes because they act as an adaptational 
mechanism in the face of a wide variety of significant stressors (Scheier and Carver, 1995). 
Optimists are more likely to conclude impediments can be overcome. These beliefs and 
continued efforts to which they give rise cause optimists to continue striving and deal with 
problems more successfully than pessimists.
DO has a demonstrable impact on cancer patients emotional functioning. Pozo et al. (1990) 
reported that optimism predicted distress over time in a prospective study of psychological 
adaptation of women to surgery for early stage breast cancer.
A number of studies have investigated which processes mediate emotional distress in breast 
cancer patients (Carver et al., 1993; Miller et al., 1996; Bjork et al., 1999; Epping-Jordan et 
al., 1999). Carver et al. (1993) found that differences in coping such as use of acceptance, 
denial and behavioural disengagement served as a mediating mechanism by which 
differences in optimism influence subjective wellbeing in women with early stage breast 
cancer. Epping Jordan et al.’s (1999) study investigated whether background dispositional 
factors including DO, specifically predict anxiety and depression in women with newly 
diagnosed breast cancer. They reported that DO had a direct relationship to anxiety and 
depression symptoms at diagnosis and six months follow up. High DO also predicted the
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proximal variable of greater emotion-focused disengagement coping, which in turn predicted 
higher anxiety and depression symptoms.
Therefore, there is evidence that DO protects individuals from the negative effects of cancer, 
and that low optimism is involved in poor psychological adjustment such as depression.
Illness Representations [IR]
Patient’s cognitive representations of illness and coping behaviours are viewed as 
particularly important determinants of adaptive coping outcome in chronic illness (Meyer et 
al., 1985; Petrie and Weinman, 1997). Upon symptom appearance, diagnosis or during the 
illness experience, individuals’ construct a representation of their health threat, which then 
influences their behaviour. Leventhal and Nerenz (1983) identified five dimensions of this IR 
in terms of which most people think of their disease. These are identity, cause, consequences, 
time line and curability.
Research to date has disregarded the possibility that IR’s act as predictors of psychological 
adjustment to cancer. Buick (1997) examined IR of breast cancer patients coping with 
radiotherapy and chemotherapy. Buick reported that negative illness beliefs were associated 
with maladaptive psychological responses. Schema composed of more moderate and positive 
illness perceptions promoted psychological adjustment far more than those composed of the 
negative dimensions of cancer did.
No data are available on the association of IR and depression among cancer patients. Moss- 
Morris et al. (1996) studied variables relevant to depression in chronic fatigue syndrome.
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Depressed CFS patients had the most pessimistic illness beliefs and internal, uncontrollable 
attributions.
Conclusions
Evidence indicates that DO, self-efficacy for coping and IR are relevant constructs to be 
investigated in relation to depression and psychological adjustment in cancer patients. To 
date no studies have been located that examine either the relationships between self-efficacy 
for coping and depression and IR and depression or the interrelationships between these 
variables in individuals with cancer.
The importance of studying DO’s relationship to depression in cancer patients alongside self- 
efficacy for coping is due to the fact that DO’s protective role in psychological adjustment in 
cancer both directly and via coping strategies may be intrinsically changed if self-efficacy 
expectations for coping are low. Judgements of little or no ability to mount coping resources 
to meet the demands of cancer could influence the initiation and use of the coping strategies, 
which mediate DO’s protective role and make individuals less likely to conclude that 
impediments can be overcome. The converse position wherein patients have high self- 
efficacy for coping with the demands of cancer, but low DO is also intriguing. Despite 
judgements supporting the ability to cope, if there is no generalised expectancy for positive 
outcomes as proposed by Scheier and Carver (1995) patients may not continue to strive to 
deal with problems related to cancer and initiate active and complex coping strategies.
Therefore the aims of this study are to examine the relationship of self-efficacy for coping 
with cancer and DO and IR among cancer patients. Additionally the relationship between 
cancer self-efficacy and DO will be examined. It is hypothesised that higher levels of
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optimism and self-efficacy for coping respectively will be associated with lower levels of 
depressive symptomatology. It is also hypothesised that low efficacy expectations will be 
associated with less depressive symptoms in patients’ with high DO than low DO.
METHOD 
Design
This study utilised a cross sectional between groups design.
Participants
Forty-seven patients with a variety of cancer diagnoses were recruited and 44 patients 
screened at a specialist cancer centre and two district general hospitals in the West of 
Scotland. The main method of recruitment for out-patients was through posters and leaflet 
advertising for people who had developed symptoms of low mood since their cancer 
diagnosis. Patients who were interested in participating completed tear-off slips, which were 
collected on a weekly basis from various centres. A variety of key personnel involved in 
routine care at the cancer centre were also involved in identifying suitable participants for 
this study, including medical and clinical oncologists, radiographers and clinical nurse 
specialists. There were a number of inclusion and exclusion criteria for both groups:
Participants Common Inclusion Criteria for Both Groups
Aged between 16-65 years.
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- Recent diagnosis of cancer (approximately 0-6 months)
- All participants diagnosed with stages 1, 2, (localised disease) or 3 (regional disease).
All participants diagnosed with cancer (Breast, Colorectal, other or leukaemia).
Participants Common Exclusion Criteria for Both Groups
- Impaired cognitive ability -  demonstrating evidence of dementia or acute confiisional 
state. ( was assessed via clinician judgement)
Additional Inclusion Criteria for the Depressed Group
- Those who obtained a score of >11 on the Hospital Anxiety and Depression Scale 
(HADS) depression subscale and an index of >50 on the Zung Self-rating Depression 
Scale (ZSDS) ( See Measures Section)
Additional Inclusion Criteria for the Non-depressed Group
Those who obtained a score which is <10 on the HADS depression subscale and <50 on 
the ZSDS
There was no comparable study on the basis of which to compute a power calculation. 
However there are data on the samples used to develop version one of the Cancer Behavior 
Inventory (Merluzzi and Martinez-Sanchez, 1997). The helplessness/hopelessness scale of 
the Mental Adjustment to Cancer Scale (Watson et al., 1988) has been used as a proxy 
measure of depression. Using these data (see appendix 4.1), which was obtained via personal 
communication with the principal author of the CBI, a minimum of 16 participants per group 
will be required to detect significant differences (P<0.05) on a paired sample t-test with 0.8
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power (one-tailed). Therefore 32 participants will need to be recruited for this study. 
Procedure
Once identified, potential participants were contacted by telephone or seen on a ward to 
ascertain if they met inclusion criteria for the study and to arrange an appointment to explain 
the study and complete the research materials. Those individuals who met the inclusion and 
exclusion criteria, agreed to participate in the study and signed the informed consent form 
were administered the self-report battery (See Measures Section). Demographic, illness and 
treatment information was also elicited. Individuals who had difficulty completing the forms 
due to physical disability or treatment factors e.g. leukaemia patients on constant IV 
medication (n=3) were read each item by the principal investigator, who also recorded their 
responses. The entire procedure took no longer than one hour. The SPSS for Windows 
statistical package, version 9.0 was used to analyse data.
Measures
Self-efficacy for coping with cancer. The Cancer Behavior Inventory Version 2.0 (CBI-L 2.0: 
Merluzzi & Martinez Sanchez, 1997; Merluzzi & Martinez Sanchez, 2001) - was used to 
measure self-efficacy for coping with cancer. The 33 item long form (CBI-L version 2.0) was 
revised in 1999. Sample items are as follows: 1. Coping with hair loss 2. Expressing negative 
feelings about cancer 3. Asking physicians questions. Items are rated on a nine-point Likert 
Scale from “not at all confident” to “totally confident”. A total efficacy score is obtained by 
adding the scale value of each of the items. The scoring ranges between zero and 297. The 
CBI-L has a seven-factor structure. These factors are Maintenance of Activity and 
Independence, Seeking and Understanding Medical Information, Stress management, Coping
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with Treatment Related Side-Effects, Accepting Cancer/Maintaining a Positive Attitude, 
Affective Regulation and Seeking Support. The a  for the CBI was 0.94, the test-retest (1 
week) reliability coefficient was 0.74.
Optimism. The Life Orientation Test (LOT; Scheier & Carver 1985; Scheier, Carver & 
Bridges 1994) was used to measure dispositional optimism. The LOT is an eight item self- 
report scale (plus four filler items -  to disguise the underlying purpose of the test) that yields 
a continuous distribution of scores from zero-48. A sample item: “In uncertain times, I 
usually expect the best.” Each item is scored on a five-point Likert Scale from “strongly 
disagree” to “strongly agree”. In validation studies (Scheier et al., 1994) internal consistency 
was a  = .78. The test re-test reliability coefficient was 0.79 over a four-week interval and 
0.72 over a 13-week interval, suggesting that the LOT possesses reasonable stability across 
time.
Illness Representations. The Revised Illness Perception Questionnaire (IPQ-R; Weinman, 
Petrie, Moss-Morris & Home, 1996; Weinman et al., 2001) was used to record illness 
representations. This questionnaire has been developed to assess the cognitive 
representations of illness. It comprises nine subscales providing information on five 
dimensions underlying the cognitive representation of illness. A sample item is as follows: “ 
my illness is easy to live with”. The items are rated on a 5-point likert scale from “strongly 
disagree” to “Strongly agree”. There are 12 items in the identity subscale, which enquires 
about the symptoms experienced. Yes/No responses are required. The remaining subscales 
contain 50 items, and the Causes subscale has 18 items. The subscales and their internal 
reliability and 6 month retest reliability are as follows: Identity (a  = .78/ .57), Time-Line 
(Acute /Chronic a  = .89/. 55 and cyclical a  = .79/. 35), Consequences (a  = .84/. 74, Control
(Treatment a  = .80/. 50 and Personala = .81/. 57), Illness coherence (a  = .87/. 53), 
Emotional Representation (a  = .88/. 81).
Depressive symptomatology.
Hospital Anxiety and Depression Scale (HADS; Zigmond & Snaith, 1983) -  The HADS is a 
14 item self-report scale, which was developed specifically for the measurement of 
depression and anxiety in physically ill populations. The depression and anxiety subscales 
each contain seven items. Scores range from 0-21 on each subscale, with questions 
individually rated on a four-point scale. A sample item is as follows: “I still enjoy the things I 
used to enjoy”. Internal consistency of the depression items ranged between +.30 and +.60, 
significant at p<0.02. Ravasi et al.’s (1990) validation study of the HADS in a cancer 
population included convergent validity between the HADS and the Montgomery & Ashberg 
Depression Rating Scale (MADRS; Montgomery and Ashberg, 1979). The correlations 
between the depression scores of HADS and the MADRS were at least 0.70.
The Zung Self-rating Depression Scale (ZSDS) (Zung, 1965) is a 20 item scale involving 
ratings on a four-point qualitative temporal scale (“a little of the time”, “some of the time”, 
“good part of the time”, and “most of the time”). Items are scored 1,2,3 and 4 respectively, 
with higher scores indicating more depression. The Zung rating scale has recently been used 
successfully as a screening tool for depression in a cancer population. Internal consistency 
was calculated as a  = 0.84 (Dugan et al., 1998). Reynolds and Gould (1981) reported a 
correlation of +0.57 with the Beck Depression Inventory.
Two measures of depressive symptomatology were administered. The principle reason for 
employing two measures was because the HADS depression subscale is limited by being
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largely based on the anhedonic state. Despite inclusion of somatic items, The ZSDS contains 
items which are representative of other psychopathological features of depression. It was 
anticipated that a composite score might overcome the limitations of either scale and increase 
the likelihood of identifying participants with depressive symptomatology. Agrell and Dehlin 
(1989) evaluated stroke patients with the ZSDS and other measures of depression (the Centre 
for Epidemiologic Studies Depression Scale (CES-D) and the Hamilton Depression rating 
Scale (HDRS)). The authors concluded that the sensitivity and predictive value was most 
accurate with a composite of the ZSDS and the CES-D. Therefore providing a precedent for 
using a composite of two depression measures in a physically ill population. The term 
“depression” in the present study refers to depressive symptomatology and does not signify a 
diagnosis of depressive disorder.
Functional Status. The Kamofsky Performance Status Scale (KPS; Karnofsky and 
Burchenal, 1949) is a rating scale commonly used by oncologists to quantify the extent of 
impairment in functional status. Although the KPS is in widespread use with cancer patients, 
its psychometric properties have not been established (Donovan et al., 1989). The KPS was 
included in this study because it is the most frequently used instrument to assess functional 
status in cancer patients and the current investigation wanted to ensure that there was no 
systematic variation in functional status between groups. A low KPS score indicates a high 
level of physical disability.
RESULTS
In order to optimally describe the interrelationships between self-efficacy for coping, DO and 
depression, results are presented in stages. Descriptive statistics were used to describe the 
sample characteristics. Independent t-tests were used for interval data and Mann Whitney-U
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tests to compare groups, which did not meet the assumptions necessary to perform 
parametric analysis. Pearsons and Spearmans rho correlations were used to determine 
relationships between data. ANOVA examined potential relationships between self-efficacy 
for coping, DO and depression and regression analyses highlighted predictive relationships 
among the psychological variables and depression.
Patient characteristics
Forty-seven patients were recruited to the study. Three patients refused to participate due to 
exacerbated physical illness (refusal rate = 1.4%). Of those who declined to participate, two 
were female and one male. Both females had diagnoses of breast cancer and the male had a 
diagnosis of prostate cancer. All three had been diagnosed within the past six months. Seven 
patients were screened out, as they did not meet the inclusion criteria for length of time since 
diagnosis (3.3%). The seven patients who were screened out comprised of five females and 
two males. Their mean age (± SD) was 51.2 ± 6.3 years. The proportion who were married 
was 71.4% (n=5), 57.1 % (n=4) were employed and 42.6% (n=3) had been in further 
education. All five females were diagnosed with breast cancer and the two males had 
diagnoses of colorectal cancer. Using the nomenclature of the American Joint Committee on 
Cancer (1992) to classify participants’ cancer stage: Four patients (57.1%) had localised 
disease (stage 1 and 2) and two patients (28.5%) had regional disease (stage 3) and one 
patient (14.3%) had metastatic disease (stage 4). All the patients who were screened out had 
undergone surgery and received adjuvant treatment.
Of the remaining 37 participants who were included in the final sample, eight were male and 
29 were female. Mean age of participants was 53.8 ± 8.3 years. The majority of participants 
was married (78.4%), employed (62.2%), and 48.6% percent had been in further education.
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The most common cancer types included breast (n=23), leukaemia (n=5) as well as a variety 
of other diagnoses (n=9). The majority of participants’ cancer stage was classified using the 
nomenclature of the American Joint Committee on Cancer (1992): 21(56.8%) participants 
had localised disease (stages 1 and 2), seven (18.9%) had regional disease (stage 3) and four 
(10.8%) participants had metastatic disease (stage 4). The remainder of participants had a 
diagnosis of Leukaemia. These five participants were diagnosed with Acute Myeloblastic 
Leukaemia (AML). According to the French-American classiification (FAB): three 
participants had undifferentiated myeloblastic leukaemia (MO), and two participants had 
myeloblastic leukaemia with maturation (M3). The mean length of time from diagnosis to 
participation was 4.1 ±1.3 months. Most patients had undergone surgery at the time of the 
diagnosis (n=29, 78.4%). All participants had received adjuvant treatment (23 chemotherapy, 
23 radiotherapy and 10 radiotherapy and chemotherapy). All were receiving treatment when 
they participated. Six participants (16.2%) had a previous diagnosis of cancer and 14 (37.8%) 
had a history of depression.
Visual inspection of the descriptive statistics indicated that there was no systematic variation 
between those patients who refused to participate and were screened out and the participants 
in the final sample in terms of demographic, illness and treatment characteristics. A 
comparison of demographic, illness and treatment characteristics of participants in the 
depressed and non-depressed groups demonstrated that both groups were comparable in age, 
gender, time since diagnosis, type of medical therapy, stage of disease and scores on the KPS 
scale (see Table 1). Use of chi-square tests of independence for the categorical variables and 
t-tests for the interval variables demonstrated that there were no significant differences 
between the depressed and non-depressed groups on the aforementioned variables (see Table 
1).
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INSERT TABLE 1 HERE
DO and Depression
It was hypothesised that higher levels of DO would be associated with lower levels of 
depressive symptomatology. This was examined using independent sample t-tests, which 
indicated that there was a significant difference between the depressed and non-depressed 
group in DO (t = 4.23, df = 35, p= .000). The depressed group having significantly lower 
dispositional optimism (mean score on LOT = 15.19 ± 5.0) than in the non-depressed group 
(mean score on LOT = 22.62 ± 5.5). This confirmed hypothesis one, which predicted that 
higher DO would be associated with lower depressive symptomatology.
Self-efficacy for coping and Depression
It was hypothesised that lower self-efficacy for coping beliefs would be associated with 
higher levels of depressed symptomatology. This was examined using a Mann Whitney U 
test, which indicated that there was a significant difference between the depressed and non- 
depressed group in self-efficacy for coping (U = 36.00, N1 =21, N2 = 16, p < .001, one 
tailed). The depressed group having significantly lower self-efficacy for coping (mean score 
on CBI = 154.88±43.9) than the non-depressed group (mean score on CBI = 223.05±29.6). 
This confirmed hypothesis two, which predicted that a lower level of self-efficacy for coping 
would be associated with higher depressive symptomatology.
A series of correlations was carried out to examine the relationship between depression and 
the factors of self-efficacy for coping. Due to the number of correlations, the Bonferroni 
adjustment procedure was used and p<0.007 (i.e.0.05/7) was considered significant because 
the correlations were calculated for depression and seven coping self-efficacy factors.
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Significant negative correlations were found between depression and these factors. The 
highest correlation was between depression and self-efficacy for accepting 
cancer/maintaining a positive attitude (see Table 2).
INSERT TABLE 2 HERE
Illness representations and Depression
An independent samples t-test indicated that there were no significant differences between 
the depressed and non-depressed group in IR (t = -. 055, df = 35, p =. 956).
A series o f correlations was carried out to examine the relationship between depression and 
the dimensions of illness representation. Given the number of correlations, a more stringent 
significance criterion indicated by the Bonferroni adjustment procedure was used and 
p<0.006 (i.e.0.05/8) was considered significant because the correlations were calculated for 
depression and eight dimensions of IR. There were no significant associations between 
depression scores and dimensions of IR (see Table 3).
INSERT TABLE 3 HERE
DO and Self-efficacy for coping
A series of correlations was carried out to examine the relationship between DO and the 
factors of self-efficacy for coping. Given the number of correlations, the significance 
criterion indicated by the Bonferroni adjustment procedure was used and p<0.007 (i.e.0.05/7) 
was considered significant because the correlations were calculated for DO and seven coping 
self-efficacy factors. Significant positive correlations were observed between DO and these 
factors (see Table 4).
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Two measures of depression were employed. There was a significant positive correlation of 
0.87, (p<0.001) between the scores on the HADS and ZSDS.
ANOVA
It was hypothesised that low coping efficacy expectations would be associated with less 
depressive symptoms in patients with high DO than low DO. The interaction between high 
and low dispositional optimism and high and low self-efficacy ratings was examined on 
depressive symptoms using a 2x2 between subjects ANOVA. Participants were split into 
high and low self-efficacy for coping groups at the median CBI score and high and low DO 
groups at the median LOT score. The number of participants in the four configurations of 
dichotomised self-efficacy for coping and DO i.e. cell sizes in the ANOVA were unequal and 
can be found in Table 5. There was a significant main effect of self-efficacy for coping (F
(1.33) = 8.29, p=0.007). The main effect of DO was not significant (F (1,33) = 2.211, p= 
0.147). There was no significant interaction between self-efficacy for coping and DO (F
(1.33) = 1.598, p= 0.215). This result does not support the hypothesis that low coping 
efficacy expectations would be associated with less depressive symptoms in patients with 
high DO than low DO. The main effect for self-efficacy for coping indicates that there is a 
significant difference in mean depression scores between the people in the high self-efficacy 
for coping group and the low self-efficacy for coping group. The lack of main effect for DO 
and the lack of any interaction between self-efficacy for coping and DO indicate that the 
mean depression scores for those with low and high DO are not significantly different and 
that self-efficacy for coping and DO did not have a combined effect on depression scores.
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High DO did not buffer against depression irrespective of level of self-efficacy for coping as 
predicted by the hypothesis.
INSERT TABLE 5 HERE
To evaluate the relationship between the full range of scores on the continuous variables of 
self-efficacy for coping and DO and depression, a hierarchical model of regression analysis 
was used with the total depression score on the HADS as dependent variable. The 
hierarchical model enters each independent variable in a series of separate steps based on a 
predetermined order. This procedure facilitates assessment of the significance of R for each 
variable. In the regression analysis, there were two predictor variables: self-efficacy for 
coping and DO. Examination of the beta values indicated that self-efficacy for coping made 
the biggest contribution towards predicting depression. DO did not significantly add to the 
variance explained in depression scores when self-efficacy was in the equation. The self- 
efficacy for coping factor alone accounts for between 47% and 48% of the variance, when 
DO is added to the coping self-efficacy as a predictor, the variance in depression scores 
accounted by these two factors together increases only by a few percent to between 50 and 
53% and DO retains no significance as a predictor. Therefore only self-efficacy for coping 
was retained (see Table 6). This result establishes that when the full range of scores on the 
continuous variables of self-efficacy for coping and DO are considered, self-efficacy for 
coping accounts for a significant proportion of the variance in depressed scores. This result 
does not support hypothesis three.
INSERT TABLE 6 HERE
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DISCUSSION
In accordance with the hypotheses, independent t and Mann Whitney U tests demonstrated 
that self-efficacy for coping and DO were significantly lower in the depressed group. 
Examination of the descriptive statistics and use o f independent t and Chi-square tests 
established that demographic, illness and treatment factors were not variables that 
differentiated the depressed and non-depressed groups. Therefore addressing the possibility 
that factors such as older age, more functional disability, more advanced stages of cancer or 
previous history of depression might be more prevalent in the depressed group and 
responsible for creating more depressed symptoms.
Statistically significant negative correlations between depression and the factors of self- 
efficacy for coping indicated that depression increases as self-efficacy for coping decreases. 
This result goes beyond Beckham et al.’s (1997) findings where self-efficacy for coping with 
cancer related symptoms was only significantly related to negative affect. The current study 
provides evidence that self-efficacy in other domains of coping such as maintenance of 
activity and independence, seeking and understanding medical information, stress 
management, accepting cancer, affective regulation and seeking support also have a 
statistically significant relationship with depressed symptoms in cancer patients.
The final hypothesis of the study which predicted that low efficacy expectations would be 
associated with less depressive symptoms in patients with high DO than low DO was tested 
using a two-way between subjects ANOVA. This hypothesis was not supported as only a 
significant main effect for self-efficacy for coping was obtained. No main effect for DO or 
any interaction between low and high self-efficacy for coping and low and high DO was
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observed. It was expected that a high level of DO would buffer against depressive symptoms 
even if self-efficacy for coping was low because it acts as an adaptive mechanism to stressors 
by promoting the belief that impediments can be overcome (Scheier and Carver, 1995), 
however, low self-efficacy for coping was associated with higher depression scores both 
when DO was low and high. The ANOVA highlighted that self-efficacy for coping is more 
influential than DO in depression scores and that a high level of DO did not compensate for 
low self-efficacy for coping. One potentially confounding factor in relation to the ANOVA 
result was that there were unequal cell sizes (see Table 4), which could suggest that self- 
efficacy for coping and DO were not entirely independent, making it difficult to ascertain 
what was actually influencing depression scores.
Examination of the influence of the full range of scores of the continuous variables of self- 
efficacy for coping and DO on depression using a regression analysis permitted comparisons 
with previous studies which investigated how a domain o f self-efficacy for coping relates to 
depression (Beckham et al., 1997), and DO’s relationship to depression (Carver et al., 1993; 
Miller et al., 1996; Epping-Jordan et al., 1999). The result of this analysis re-iterated the 
findings on the ANOVA. Self-efficacy for coping accounted for 47-48% of the variance in 
depression scores independently and the addition of DO did not explain any further variance 
in the depression scores.
Examination of self-efficacy for coping and DO’s respective relationships to depression may 
help to explain why self-efficacy for coping both as a variable with low and high levels and 
in its actual amounts was more influential in depression than DO. Previous studies have 
established that DO’s protective role in psychological adjustment in cancer operates through 
a direct relationship to distress and depression and via coping strategies (Scheier and Carver,
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1985; 1993). When self-efficacy for coping is low, there are judgements of little or no ability 
to mount coping resources (Merluzzi and Martinez-Sanchez, 1997) which influence the 
initiation of coping strategies which will in turn influence depression directly and could 
possibly change DO’s protective role, thereby further increasing vulnerability to depression. 
DO motivates people to problem solve and initiate coping strategies. However in the context 
of a judgement that there is little that can be done to meet demand the individual may 
conclude they cannot overcome the impediment and desist from coping attempts. 
Situationally-defmed self-efficacy for coping may have proven to be more pertinent in 
determining coping activity than the trait variable DO, and hence varied more closely with 
depression.
Another proposition that may explain self-efficacy for coping’s apparently exclusive role in 
depression suggests that the construct of self-efficacy for coping overlaps conceptually with 
DO. There is evidence that one source of cancer patients’ self-efficacy for coping 
expectations may be their ‘positive illusions’ or schemas of themselves and the disease. 
These illusions are distortions that enhance positive self-evaluations, maintain perceptions of 
control, and promote an optimistic perspective (Taylor and Brown, 1988). In Merluzzi and 
Martinez Sanchez’s (1997) study of cancer patients’ perceptions of coping behaviours, they 
found that patients with high self-efficacy for coping reported schemas that fostered positive 
illusions. These illusions related to self-enhancing perceptions of personal qualities, 
exaggerated belief in personal control, beliefs that they could accomplish tasks and had the 
means to do so. Engaging in this perspective was associated with more positive coping 
expectations and adaptation to cancer. If situationally-driven optimistic schemas are a source 
of self-efficacy for coping expectations in cancer patients, it may explain why this variable 
had such a dominant relationship with depression in the current study. The role of these
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optimistic schemas in the self-efficacy for coping dimension could have confounded the role 
of trait DO in the analysis, leading to the current result, whereby DO did not compensate for 
low self-efficacy for coping nor have any unique predictive value in depression.
The relationship established between self-efficacy for coping and depression in the current 
study furthers Beckham et al.’s findings (1997). They found no relationship between self- 
efficacy for cancer-related symptoms and depression. It is possible that self-efficacy for 
coping accounted for a significant proportion of the variance in depression in the current 
study because efficacy judgements across more domains of coping were considered. 
Therefore when an increased number of coping areas and therefore cancer-related tasks were 
considered in this study compared to Beckham et al.’s study a stronger relationship with 
depression was established. This suggests that perception of ability to manage demands is 
indeed a relevant variable in depression when a comprehensive and realistic set of demands 
is considered.
The role of self-efficacy for coping in depression established in this study concurs with 
Lightsey’s (1997) findings regarding the role of generalised self-efficacy as a stress buffer in 
negative life events. Social cognitive theory explains why self-efficacy buffers stress, it 
suggests that people who believe in their ability to cope with particular stressors exhibit 
greater actual coping ability when the situation requires it, compared to those who do not 
believe they have the requisite ability (Bandura, 1982). These people develop more realistic 
goals, persist longer at goal attainment and modify their goals less often than individuals 
with low efficacy (Bandura, 1997). O’Leary et al. (1988) and Beckham et al. (1994) posit 
that self-efficacy for coping may also protect against depression in chronic illness because it 
motivates individuals to pursue adaptive activity despite physical limitations. The
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relationship between self-efficacy for coping and depression established in the current study 
parallels the results reported by Parle and Maguire (1995,1996). They reported that the 
coping process variable of appraisal was predictive of affective disorder in cancer patients. 
Their definition of primary and secondary appraisals concur closely with the definition of 
coping self-efficacy, and they reported that helpless responses which are better understood as 
negative secondary appraisals (perception of ability to manage demand) were also predictive 
of depression.
The relationship established between self-efficacy for coping and depression could also 
indicate that depressed symptoms negatively affected participants’ views of their ability to 
cope with cancer-related demands and that low coping efficacy was simply a facet of being 
depressed. However the converse position where judgements of inability to meet the 
demands of cancer caused vulnerability to depression is equally tenable. This study 
employed a cross-sectional design, which did not allow for the direction o f the relationship 
between self-efficacy for coping for cancer and depressed symptoms to be explored.
Optimism
As predicted, level of DO was significantly lower in the depressed group. This result broadly 
supports previous findings which have established that optimism is reliably related to 
psychological distress and depression in cancer patients (Carver et al., 1993; Miller et al., 
1996; Epping-Jordan et al., 1999). However in the current study, DO did not account for any 
unique variance in depression, whereas both Miller et al. and Epping-Jordan et al. reported 
that DO was predictive of depression both directly and mediated via coping strategies, i.e.
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DO predicted greater emotion-focused disengagement coping, which in turn predicted higher 
depressed symptoms. Therefore this result is inconsistent with prior research and bears 
comment. This inconsistent result maybe attributable to sample differences. For example the 
current sample was considerably smaller than those in most optimism studies. Alternatively, 
instrument differences maybe responsible. The current study, unlike most previous studies of 
optimism, utilised a combined HADS depression subscale and ZSDS score as a discrete 
outcome measure. Most optimism studies use alternative measures of general mood. Carver 
et al. 1993 assessed distress using the Profile of Mood States (POMS; McNair, Lorr and 
Droppelman, 1971). Emotional distress scores are often reported which are composites of 
anxiety and depression symptoms (Epping-Jordan et al., 1999) rather than measures of 
depression per se. Therefore the current study has improved upon previous practice of 
measurement of depression in optimism studies by utilising measures that are known to 
reliably measure depression.
DO’s stability as a dispositional resource in the context of the current stressor of cancer may 
be a pertinent factor in the relationship established with depression in the current study. 
Scheier and Carver, (1985) suggest that DO is a general and stable dispositional resource 
which does not change across life, one which will influence how we respond trans- 
situationally. However, debate exists about the nature of optimism and indeed, what the LOT 
is actually measuring. Situational optimism refers to positive outcome expectancies for 
specific situations. These expectancies are more proximal to stressful events than 
dispositional beliefs, and therefore could prove to be important predictors of psychological 
responses to specific stressors like cancer. The situation specific expectancies that may have 
been influential on responses on the LOT would probably be strongly informed by situation-
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specific variables such as self-efficacy for coping. Indeed the current study found strong 
associations between DO and self-efficacy for coping, and this may explain why DO does 
not account for any added variance in the depression scores.
A recent comparison of the LOT with another optimism questionnaire, the Optimism 
Pessimism Scale (OPS) indicated that the two were not measuring similar constructs and that 
the LOT was measuring trait optimism, whilst the OPS was tapping state optimism (Burke et 
al., 2000). Taylor et al. (1992) also found that trait and state measures of DO were only 
modestly correlated (r=. 18) and that the two types o f measure predicted different patterns of 
psychological outcomes.
There has been criticism of the LOT in regards to whether it can reliably predict unique 
variance, and of the construct of DO itself. Smith et al. (1989) highlight the third variable 
problem and suggest that the LOT is difficult to distinguish from measures of neuroticism 
and that studies using the LOT may be more parsimoniously interpreted as reflecting 
neuroticism rather than DO. Similarly, in studies on self-mastery and DO in women 
professionals and of self-esteem as predictors of post-partum depression DO, was unable to 
predict various outcomes following statistical control of the variance associated with related 
predictors (Marshall and Lang, 1990; Fontaine and Jones, 1997). It has already been 
suggested that there may be conceptual overlap between self-efficacy for coping and DO. 
During their validation studies on this measure of self-efficacy for coping in cancer the 
authors of the CBI also reported that that it was highly associated with DO on the LOT 
(Merluzzi and Martinez Sanchez, 1997). This may explain the lack of unique variance in 
depression accounted for by DO. Scheier at al. (1994) re-evaluated the LOT and found that 
associations between depression and DO remained significant following statistical control of
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trait anxiety, self-mastery and coping. However there has been no previous evaluation of the 
predictive and discriminant validity of DO alongside the variable of self-efficacy for coping.
The main findings of the study regarding self-efficacy for coping, DO and depression have 
been discussed in the context of cancer, however the relationships established between self- 
efficacy, DO and depression are not specific to cancer or people with physical illness. These 
variables have been shown to interact similarly in the general population. According to 
Bandura’s (1982, 1986) reformulation of the relationship between self-efficacy and 
depression, when individuals believe that highly desired outcomes are obtainable through the 
performance of certain behaviours, and believe they are incapable of performing the requisite 
behaviours (low self-efficacy expectancy), they display low rates of behavioural initiative 
and persistence, self-devaluation and depressed affect. The current study demonstrated that 
low self-efficacy for coping with the demands associated with cancer was strongly predictive 
of depressive symptomatology. Lightsey’s (1997) prospective study of stress buffers and 
dysphoria is a particularly good example of the similarity of the relationships established 
between self-efficacy, DO and depression in a non-clinical sample representative of the 
general population and in the physically ill population of the current study. This study 
examining multiple predictors of depression tested whether generalised self-efficacy [GSE] 
and optimism act as stress buffers and found that when exposed to stressors, persons with 
high GSE may become less dysphoric than persons with lower GSE. This study also found 
that optimism had little effect on dysphoria per se above the effects of GSE, negative life 
events and negative thoughts. The inference being that depression is significantly related to 
individuals’ confidence to approach tasks that have highly valued outcomes in both the 
physically ill and general population. The role of self-efficacy may indeed be in partnership
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with other long-standing cognitive variables, which also try to explain self-regulatory 
behavioural phenomena, however these relationships require further investigation. Peterson 
et al. (1993) posited that it is individuals’ manifest thoughts and beliefs that pertain most 
directly to their health and emotional wellbeing. Beliefs that are infused with agency and 
efficacy lead to health promoting activities. Those that result in passivity and demoralisation 
do not.
Illness Representation
i
The current literature did not warrant specific hypotheses regarding IR in cancer patients and 
indeed depression, therefore the aim of the current study was to provide a description of the 
IR of the sample and to highlight any relationships with depression. The results of this study 
indicated that there were no significant differences in IR between the depressed and non­
depressed groups. There were no significant correlations between depression and IR 
subscales either. Moss Morris et al. (1997), examined IR in CFS patients and observed that 
representations of CFS as a serious and uncontrollable disease were associated with less 
psychological wellbeing and strongly predicted levels of distress. It was therefore expected 
that depression in the current sample would associate with higher scores on the identity, 
consequences, controllability and emotional representations of the IPQ. An explanation for 
the lack of association may be that as opposed to the Moss Morris CFS sample, the current 
sample was heterogeneous, including many different cancer types, with varied lengths of 
time since diagnosis and different treatment stages. These factors might have caused 
considerable diversity in responses and confounded any consistent pattern of association with 
depressed symptoms.
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Certain limitations are to be considered in evaluating the results of this study. The use of a 
composite measure of depressed symptomatology using the HADS and ZSDS may not have 
been necessary to ensure that depression was accurately measured as the high correlation 
between these two measures indicated that each individual measure of depression was as 
stringent as the composite. Another limitation o f the study was that all of the variables were 
self-reported at a single measurement point. Therefore, an unknown portion of the observed 
correlations could have been attributable to conceptual and content overlap among the scale 
items. An important direction for future research in this area could be to use longitudinal and 
experimental designs for investigation of specific hypotheses regarding the relationship 
between self-efficacy for coping, DO and depression in cancer patients. Interpretation of the 
results obtained requires caution as a small sample size resulted in difficulty in accurately 
examining the relationship between high and low self-efficacy and DO and depression. A 
larger sample could have resulted in greater statistical power and a greater likelihood of 
finding significant results. It was anticipated that the depressed and non-depressed group 
would be matched according to age, gender, and cancer type to reduce variation among the 
two groups. However, due to recruitment difficulties and time constraints, it was not possible 
to conduct a matched pair design. A number of cancer types were also included, and future 
research should aim to include matched groups in order to identify variables which are 
relevant to depression in each specific cancer type. Using a cross-sectional design precludes 
making any causal inferences. Several different causal relationships could have produced the 
associations found and a prospective study would be necessary to infer causality. Self-report 
measures were used exclusively in the study, further studies could use clinical interviews for 
depression and structured interviews to more comprehensively assess coping-related 
variables.
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Whilst there is considerable support for an inverse relationship between DO and depressive 
symptoms in cancer patients, further research could examine situation-specific influences on 
what is measured by the LOT and study the relationship of state and trait optimism with 
depression simultaneously. A longitudinal prospective study could also examine the 
relationship between self-efficacy for coping with cancer and actual coping responses and 
resolution of demands and assess the accuracy of self-efficacy for coping judgements in 
predicting coping behaviour and ascertain which variable is more closely associated with 
depression, the self-efficacy judgement or the actual coping response. This would involve the 
use of a structured interview for coping.
Depressed cancer patients in this study exhibited significantly lower DO and self-efficacy for 
coping with cancer. However DO did not buffer against depression when self-efficacy for 
coping with cancer was low. The current study established that self-efficacy for coping 
played a protective role in depression. High self-efficacy for coping may have motivated 
individuals with cancer to develop and persist with goal attainment and pursue activity, 
which is likely to buffer against depression. Self-efficacy for coping may have confounded 
the role of DO in the analysis due to conceptual overlap and the role of positive 
illusions/optimistic schema within the self-efficacy for coping construct. However perceived 
capability to exercise control, whether illusory or real but unexercised, appears to decrease 
emotional distress over aversive events, thus belief in one’s personal efficacy can, in itself 
produce benefits.
These findings on the predictiveness of self-efficacy in depression in cancer patients 
underscore the value of combining medical treatments with psychosocial treatments that
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counteract the collapse of personal efficacy to protect against depression and maintain 
quality of life. Augmenting individuals’ self-efficacy for coping in relevant domains may 
help him or her to cope more effectively with stressful life events such as cancer and avoid 
developing depression.
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Table 1: Comparison of demographic, illness and treatment variables between groups
Depressed Group Non-Depressed Group
Between Group 
Analysis
Males N = 4 N = 4 x2 = . 190(1), p= . 663
Females N =  12 N =  17
Age 56.1± 7.3 years 52.1 ± 8.8 years T = -1.447(35), p= .157
Time since diagnosis 3.9±1.3 months 4.3±1.3 months T = .821(35), p= .417
Stage of disease:
One Primary Site N = 9 N =  12
Regional Disease N = 4 N = 3 F (2,29) = .33, p= 0.968
Metastatic Disease N = 2 N = 2
Chemotherapy N =  11 N =  12 x2 = .520(1), p= .471
Radiotherapy N = 11 N =  12 x2 = .520(1), p= .471
Surgery N =  12 N =  17 x2 = .190(1), p= .663
KPS 75 ± 10.3 78.1 ±8.1 T = 1.021(35), p = .314
Previous History of  
depression
N = 8 N = 6 x2 = .190(1), p= .663
116
Table 2 Spearmans Correlations between Self-efficacy for coping factors and Depression
1 2 3 4 5 6 7
Depressed
symptoms
r = 58
p<.001
r = .60
p<.001
r = .50 
P .002
r = .46 
P=.004
r = .73 
P<.001
r = .54 
P=001
r = .61 
P<.001
Factor names were 1 = Maintenance of Activity and Independence, 2 = Seeking and understanding 
Medical Information, 3 = Stress Management, 4 = Coping with Treatment-Related Side-Effects, 5 = 
Accepting Cancer/Maintaining Positive Attitude, 6 = Affective Regulation, and 7 = seeking Support.
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Table 3 Pearsons Correlations between Illness Representation dimensions and Depression
1 2 3 4 5 6 7 8
Depressed
symptoms
r =195 
p=248
r = 241 
p= 150
r .155 
P=.360
r .198 
P=.239
r .360 
P=.029
r .149 
P=.379
r .296 
P=.075
r .404 
P=.013
Names of illness representation dimensions were 1 = Identity, 2 = Timeline -  Acute/Chronic, 3 = 
Timeline Cyclical 4 = Consequences, 5 = Personal Control, 6 = Treatment Control, 7 = Illness 
Coherence, 8 = Emotional Representations.
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Table 4 Spearmans Correlations between Self-efficacy for coping factors and DO
1 2 3 4 5 6 7
DO r = 34 
P=.002
r = .51 
P = 001
r = .51 
P=.001
r = .44 
P= .003
r = 75 
Pc.001
r = 47 
P=.002
r = 42 
P=.004
Factor names were 1 = Maintenance of Activity and Independence, 2 = Seeking and 
understanding Medical Information, 3 = Stress Management, 4 = Coping with Treatment- 
Related Side-Effects, 5 = Accepting Cancer/Maintaining Positive Attitude, 6 = Affective 
Regulation, and 7 = seeking Support.
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Table 5 -  Number of participants in high/low self efficacy for coping and DO combinations. (Cell 
sizes in the ANOVA Analysis)
High DO Low DO
High Self -efficacy for coping N =15 N=3
Low Self-efficacy for coping N=4 N=15
120
Table 6 Regression analysis summary for self-efficacy for coping and DO predicting depression 
scores
Variable B Std. Error Beta R Square Adjusted R 
Square
Step 1 enter 
individually
Self-efficacy for 
coping
-6.992E-03 .001 -.69** .48 .47
DO
-4.557E-02 .011 -.58** .34 .32
Step 2 enter together
Coping self efficacy -5.382E-03 .001 -.53** .53 .50
DO
-2.175E-02 .011 -.28 .53 .50
** p<.001
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An Investigation of the contribution of self-blame to the maintenance of intrusions, low 
mood and avoidance symptoms in posttraumatic stress disorder: A Single Case Study 
ABSTRACT
The effect of addressing dysfunctional self-blame beliefs on reported symptomatology 
(intrusions, avoidance of going outside and low mood) in a patient with a diagnosis of Post- 
Traumatic Stress Disorder (PTSD) was investigated. This single case study presents the use 
of standard cognitive behavioural techniques with a 34-year-old woman whose chronic 
PTSD had resulted in emotional, social and occupational impairment. The intervention 
comprised four sessions focusing on ameliorating self-blame for actions during the traumatic 
event and the patients reaction in terms of symptomatology after it. The patient recorded 
daily diary ratings of mood, number of intrusions and trips taken outside and completed 
psychometric measures of mood, intrusions avoidance and problematic appraisals weekly. 
The patient also rated self-blame on three self-generated cognitions relating to self-blame at 
the beginning and end of each intervention session. Both within and between session 
reductions were noted on the self-blame cognitions. Problematic self-blame appraisals 
measured by the Post Traumatic Cognitions Inventory [PTCI] were also reduced at end of 
treatment. The patient’s ratings for mood, intrusions and avoidance were also significantly 
reduced at end of treatment. The patient no longer met criteria for PTSD at end of treatment. 
These gains were maintained at one-month follow-up. Results indicated that clinically 
significant change on PTSD symptoms followed amelioration of dysfunctional self-blame. 
When discordance between the patient’s perceptions of actions during the event and pre­
trauma schemas was addressed emotional processing was facilitated, leading to a 
modification of perception of incompetence and ongoing threat and therefore preventing 
further intrusions, avoidance and low mood.
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Reasons For Care
A detailed level of description of client problems, in psychological terms, which can broadly be 
linked to the DSM IV.
ANXIETY & PHOBIAS PERSONALITY DISORDER
•
Anxiety (Nos) Obsessional Personality
jcncraliscd Anxiety Disorder Schizoid
Panic Disorder Psychopathic
Separation Anxiety mmature
Stress Adjustment ’ersonality Disorder (NOS)
Work Stress
VIonosymptomatic Phobia
Agoraphobia BEHAVIOURAL/MOVEMENT DISORDER
Social Phobia
£chool Refusal Anti-Social
Phobic Avoidance dyperactivity
Stereotypy
POST TRAUMATIC STRESS DISORDER VIotivational Disorder
Self-Injury
! ANGER Tics
Tremors
,Angcr Torticollis
(Irritability Exhibitionism
Temper Tantrums
DEPRESSION/MOOD DISORDER ADDICTIONS
.Depressed Mood Gambling
Grief Reaction Substance Use :
Mood Disorder (Nos) Drugs
1 Solvents
1 OBSESSIONAL DISORDER Tobacco
jj
j Obsessive Compulsive DEVELOPMENT/SPEECII/COGNITIVE
J Ruminations DISORDER
I
Intellectual/Memory Impairment
Attention Deficit
| EATING DISORDER Developmental delay
i Communication Disorder
Anorexia Perceptual Deficit
Bulimia Learning Disability
Over-eating , Dyslexia
Spcccli/Languagc Disorder
SLEEP DISORDER
PROBLEMS RELATED TO PHYSICAL
Insomnia ILLNESS/PAIN
Hypersomnia
Pain
Illness Behaviour.
Treatment Compliance Problem
Appendix 1.3
Reasons For Care Contd.
SEXUAL DISORDER
Sexual Identity 
Sexual Variation
Psychosexual Dysfunction_______
ELIMINATION
Enuresis
Encopresis_____________________________________
RELATIONSHIP/SOCIAL PROBLEMS
Family (NOS)
Marital
Parental Management 
Carer Management 
Peer Relationships 
Social Adjustment 
Social Relationships (NOS) 
Interpersonal Skills Deficit 
Social withdrawal 
Self-Care
Appendix 1.4
Care Aims
D efin es what the therapist is broadly trying to ach ieve. T h is is agreed with the client.
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C A N C E R  B E H A V IO R  IN V E N T O R Y  (C B I-L )
This questionnaire contains many things that a person might do when receiving treatment for 
nccr. We are interested in your judgm ent of how confident you are that you can accomplish those 
ings. Make sure your ratings accurately reflect your confidence whether or not you have done it in the 
ist. So, your ratings reflect vour confidence that you can do these things now (or in the near future).
Please read each numbered item. Then rate that item on how confident you are that you can 
complish that behavior. Circle a number on the scale. If you circle a " 1" you would be stating that you 
e not at all confident that you can accomplish that behavior. If you circle a "9" you would be stating 
at you are totally confident that you can accomplish that behavior. Numbers in the middle of the scale 
dicate that you are moderately confident that you can accomplish that behavior.
Please rate Mi items. If you are jio t sure about an item please rate it as best you can.
M a in ta in in g
in d ep en d en ce.
NOT AT ALL 
CONFIDENT 
1 2
MODERATELY 
CONFIDENT 
4 5 6 7
TOTALLY 
CONFIDENT 
8 9
M aintaining a 
p ositive  a ttitu d e.
NOT AT ALL 
CONFIDENT 
1 2
MODERATELY 
CONFIDENT 
4 5 6 7
TOTALLY 
CONFIDENT 
8 9
A ccepting that 
I have cancer.
M aintain ing  
w ork activ ity .
A sking nurses 
q u e s t io n s .
NOT AT ALL 
CONFIDENT 
1 2
NOT AT ALL 
CONFIDENT 
1 2
NOT AT ALL 
CONFIDENT 
I 2
Rem aining relaxed NOT AT ALL 
throughout CONFIDENT
treatm ents and not 1 2
allow ing scary thoughts  
to upset me.
Seek ing  support 
from people & 
groups outside  
the fam ily
B. M aintaining a 
daily routine.
9. A sk in g .
te c h n o lo g is ts  
q u estio n s .
NOT AT ALL 
CONFIDENT
1 2  3
NOT AT ALL 
CONFIDENT 
1 2
NOT AT ALL 
CONFIDENT 
1 2
MODERATELY 
CONFIDENT 
4 5 6
MODERATELY 
CONFIDENT 
4 5 6
MODERATELY 
CONFIDENT 
4 5 6
MODERATELY 
CONFIDENT 
4 5 6
MODERATELY 
CONFIDENT 
4 5 6 7
MODERATELY 
CONFIDENT 
4 5 6 7
MODERATELY 
CONFIDENT 
4 5 6 7
TOTALLY 
CONFIDENT 
8 9
TOTALLY 
CONFIDENT 
8 9
TOTALLY 
CONFIDENT 
8 9
TOTALLY 
CONFIDENT 
8 9
TOTALLY 
CONFIDENT 
8 9
TOTALLY
CONFIDENT
8 a
TOTALLY 
CONFIDENT 
8 9
l*age I
|C a NCI:R  I lliH A  V IO R ,In VI:N TOR Y 
II 'O R M -I .
V l.K S I O N  2  0
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. C oping with NOT AT ALL MODERATELY
hair loss. CONFIDENT CONFIDENT
1 2 3 4 5 6 7
. U sing d en ia l.
Rem aining relaxed
throughout
treatm ent
(ch em o th era p y ,
rad ia tion ).
3. C oping with  
p h ysica l ch an ges.
4. Ignoring th ings  
that cannot be 
dealt with.
NOT AT ALL 
CONFIDENT
1 2 3
NOT AT ALL 
CONFIDENT
1 2 3
NOT AT ALL 
CONFIDENT
1 2 3
NOT AT ALL 
CONFIDENT
I 2 3
MODERATELY 
CONFIDENT 
4 5 6 7
MODERATELY 
CONFIDENT 
4 5 6 7
MODERATELY 
CONFIDENT 
4 5 6 7
MODERATELY 
CONFIDENT 
4 5 6 7
A ctively  NOT AT ALL
p a r tic ip a tin g  in CONFIDENT
treatm en t d ec ision s. 1 2
MODERATELY 
CONFIDENT 
4 5 6
6. S h arin g  fee lin gs  
of concern.
NOT AT ALL 
^CONFIDENT 
1 2
MODERATELY 
CONFIDENT 
4 5 6
[7. R em aining relaxed NOT AT ALL 
w hile w aiting at CONFIDENT 
least one hour for 1 2
my ap p oin tm en t.
8. E x p ressin g
personal fee lin gs  
of anger or 
h o s t i l i t y .
|9. S e e k in g
NOT AT ALL 
CONFIDENT 
1 2
NOT AT ALL
in fo rm a tio n  about CONFIDENT
cancer or cancer 
trea tm en ts .
E xpressing  
n e g a t iv e  feelings  
j about cancer.
. K eeping , busy 
w ith  a c tiv it ie s .
1
NOT AT ALL 
CONFIDENT 
1 2
NOT AT ALL 
CONFIDENT 
1 2
MODERATELY 
CONFIDENT 
4 5 6
MODERATELY 
CONFIDENT 
4 5 6 7
MODERATELY 
CONFIDENT 
4 5 6 7
MODERATELY 
CONFIDENT 
4 5 6 7
MODERATELY 
CONFIDENT 
4 5 6 7
iN rr.K  l lr . i iA v io k  iN v i in r o k Y  
ikM L
tk siO N  2 .0
I
TOTALLY 
CONFIDENT 
8 9
TOTALLY 
CONFIDENT 
8 9
TOTALLY 
CONFIDENT 
8 9
TOTALLY 
CONFIDENT 
8 9
TOTALLY 
CONFIDENT 
8 9
TOTALLY 
CONFIDENT 
8 9
TOTALLY 
CONFIDENT 
8 9
TOTALLY 
CONFIDENT 
8 9
TOTALLY 
CONFIDENT 
8 9
TOTALLY 
CONFIDENT 
8 9
TOTALLY 
CONFIDENT 
8 9 ,
TOTALLY 
CONFIDENT 
8 9
131
2. Finding an 
e sc a p e .
Reducing any 
a n x ie ty
associated with 
getting my blood 
draw n.
4. M aintain ing a 
sense of humor.
p .  A ccepting
p h y sica l ch an ges  
or lim itations  
caused by 
cancer treatm ent.
£6. S e e k in g
c o n s o la t io n .
27 Reducing any 
nausea associated  
with treatm ent 
(ch em o th era p y , 
radiation)
28. M aintain ing  
hope.
29. A sking
p h y s ic ia n s
q u e s t io n s .
30 D oing som eth in g , 
anything.
NOT AT ALL 
CONFIDENT 
1 2
NOT AT ALL 
CONFIDENT 
1 2
NOT AT ALL 
CONFIDENT 
1 2
NOT AT ALL 
CONFIDENT 
1 2
NOT AT ALL 
CONFIDENT 
1 2
NOT AT ALL 
CONFIDENT 
1 2
NOT AT ALL 
CONFIDENT 
1 2
NOT AT ALL 
CONFIDENT 
I 2
NOT AT ALL 
CONFIDENT 
1 2
MODERATELY 
CONFIDENT 
4 5 6 7
MODERATELY 
CONFIDENT 
4 5 6 7
MODERATELY 
CONFIDENT 
4 5 6 7
MODERATELY 
CONFIDENT 
4 5 6 7
MODERATELY 
CONFIDENT 
4 5 6 7
MODERATELY 
CONFIDENT 
4 5 6 7
MODERATELY 
CONFIDENT 
4 5 6
MODERATELY 
CONFIDENT 
4 5 6
MODERATELY 
CONFIDENT 
4 5 6
TOTALLY 
CONFIDENT 
8 9
TOTALLY 
CONFIDENT 
8 9
TOTALLY 
CONFIDENT 
3 9
TOTALLY 
CONFIDENT 
3 9
TOTALLY 
CONFIDENT 
3 9
TOTALLY 
CONFIDENT 
8 9
TOTALLY 
CONFIDENT 
3 9
TOTALLY 
CONFIDENT 
8 9
TOTALLY 
CONFIDENT 
8 9
31 M anaging pain. NOT AT ALL 
CONFIDENT 
1 2
MODERATELY 
CONFIDENT 
4 5 6
TOTALLY 
CONFIDENT 
8 9
■2 M anaging nausea 
and vom iting.
NOT AT ALL 
CONFIDENT
MODERATELY 
CONFIDENT 
4 5 6
TOTALLY 
CONFIDENT 
S 9
' ’ C on tro llin g  my 
n egative feelings  
about cancer.
NOT AT ALL 
CONFIDENT 
1 2 3
MODERATELY 
CONFIDENT 
5 6 7 S 9
TOTALLY
CONFIDENT
C a n c l k  I J u i a v i o r  I n v e n t o r y  
I 'O R M  ■ L 
V U K SIO N  2 0
LIFE ORIENTATION TEST
Name:.......................................................................................
Date:.......................................................  Record Number:
Please be as honest and accurate as you can be throughout.Try not to let your response to one 
statement influence your responses to other statements. There are no ‘correct’ or ‘incorrect’ 
answers. Answer according tcf your own feelings, rather than how you think ‘most people’ would 
answer. Using the scale below, write the appropriate letter in the box beside each statement.
A
I agree a lot
B
I agree a little I neither agree 
or disagree
D
I disagree 
a little
E
I disagree 
a lot
1. In uncertain times, I usually expect the best.
2. It’s easy for me to relax.
3. If something can go wrong for me, it will.
4. I always look on the bright side.
5. I’m always optimistic about my future:
6. I enjoy my friends a lot.
7. It’s  important for mo to kcop  busy.
8. I hardly ever expect things to go my way.
* “ i
9. Things never work out the way I want them to.
10. I don't get upset easily.
11. I’m a believer in the idea that 'every cloud has a silver lining’.
12. I rarely count on good things happening to me.
□□□□□□□□□□□□
© Lawrence Erlbaum Associates, Inc., 1985. From 'Optimism, coping and health: assessment and implications of 
generalized outcome expectancies', Health Psychology, 4, 219-47. Reproduced with the kind permission of the authors 
and publishers.
This measure is part of Measures in Health Psychology: A User's Portfolio, written and compiled by Professor Marie 
Johnston. Dr Stephen Wright and Professor John Weinman. Once the invoice has been paid, it may be photocopied for 
use within th e  p u rc h a s in g  Institu t ion  only. Published by The NFER-NELSON Publishing Company Ltd, Darville 
House, 2 Oxford Road East, Windsor, Berkshire SL4 1DF, UK. Code 4920 09 4
©
Annpnrtiv T T Illness Perception Questionnaire 133
OUR VIEWS ABOUT YOUR ILLNESS
isted below are a number of symptoms that you may or may not have experienced since your 
ness. Please indicate~by circling Yes or No, whether you have experienced any of these symptoms 
nee your illness, and whether you believe that these symptoms are related to your illness.
I have experienced this This symptom is related to my
symptom since my illness illness
ain Yes No Yes No
ore Throat Yes No Yes ~No
ausea Yes No Yes No
reathlessness Yes No Yes No
height Loss Yes No Yes No
atigue Yes No Yes No
tiff Joints Yes No Yes No
ore Eyes Yes No Yes No
Vhceziness Yes No Yes No
leadaches Yes No Yes No
Jpset Stomach Yes No Yes No
fleep Difficulties Yes No Yes No
|)izzincss Yes No Yes No
-.oss of Strength Yes No Yes No
Ye are interested in your own personal views of how you now see your current illness.
please indicate how much you agree or disagree with the following statements about your illness by 
icking the appropriate box.
VIEWS ABOUT YOUR ILLNESS STRONGLYDISAGREE DISAGREE NEITHER AGREE NOR 
DISACREE
AGREE STRONGLY
AGREE
r My illness will last a short time
n My illness is likely to be permanent rather than 
temporaryr My illness will last for a long time
1*4* This illness will pass quickly
VIEWS ABOUT YOUR Illness STRONGLYDISAGREE DISAGREE NEITHER AGREE NOR 
DISAGREE
AGREE STRONGLY
AGREE
[1*5* 1 expert to have this illness for the rest of my 
life
U*6 My illness is a serious condition
11*7 My illness has major consequences on my life
11*8 My illness is easy to live with
Illness Perception Questionnaire 134
Vly illness does not have much effect on my life
My illness strongly affects the way others see
me
My illness has serious financial consequences
My illness strongly affects the way I see myself 
as a person____________________________ _
My illness causes difficulties for those who are 
close to me
My illness has a negative impact on me
My illness is not a problem for me
My illness doesn’t bother me much
There is a lot which I can do to control my
symptoms__________________________
What I do can determine whether my illness 
gets better or worse
Recovery from my illness is largely dependent 
on chance or fate
The course of my illness depends on me
Nothing I do will affect my illness
I have the power to influence my illness
My actions will have no affect on the outcome 
of my illness___________________________
My symptoms are beyond my control
My symptoms will be around whatever I do
My illness will improve in time
There is very little that can be done to improve 
my illness____________________________
My treatment will be effective in curing my 
illness
The negative effects of my illness can be 
prevented (avoided) by my treatment
VIEWS ABOUT YOUR ILLNESS STRONGLYDISAGREE DISAGREE NEITHER AGREE NOR  
DISAGREE
AGREE STRONGLY
AGREE
My treatment can control my illness
There is nothing which can help my condition
The symptoms of my condition are puzzling to 
me
My illness is a mystery to me
I don’t understand my illness
My illness doesn’t make any sense to me
I have a, clear picture or understanding of my 
condition
The symptoms of my illness change a great 
deal from day to day__________________
My symptoms come and go in cycles
My illness is very unpredictable
Illness Perception Questionnaire 135
p* My illness condition is present all the time.
!*• I go through cycles in which my illness gets 
better and worse.r I experience my illness symptoms pretty much 
all of the time.
o * The symptoms of my illness are distressing to 
me
44 I get depressed when I think about my illness
45* When I think about my illness I get upset
46* My illness makes me feel angry •
47* My illness does not worry me
46* Having this illness makes me feel anxious
49*
1
1 worry a lot about my illness
‘SO* My illness makes me feel afraid
CAUSES OF MY ILLNESS
136
/c arc interested in what you consider may have been the cause of your illness. As people arc very different, 
iere is no correct answer for this question. We are most interested in your own views about the factors that 
luscd your illness rather than what others including doctors or family may have suggested to you. Below is a 
st of possible causes for your illness. Please indicate how much you agree or disagree that they were causes 
ir you by ticking the appropriate box.
p o s s ib l e  CAUSES STRONGLYDISAGREE DISAGREE NEITHER AGREENOR  
DISAGREE
AGREE STRONGLY
AGREE
C l Stress or worry
C2 Hereditary - it runs in my family
a A Germ or virus
| C4 Diet or eating habits
1 CSi Chance or bad luck
1 C* Poor medical care in my past
| ir7 Pollution in the environment
1 C8 My own behaviour
C9 . My mental attitude e.g. thinking about life 
negatively
CIO Family problems or worries caused my 
illness
C ll* Overwork
C12- My emotional state e.g. feeling down, lonely, 
anxious, empty
CIJ* Ageing
C14« Alcohol
C15* Smoking
C16* Accident or injury
C17* My personality
CIS- Altered immunity
In the table below, please list in rank-order the three most important factors that you now believe caused 
YOUR illness. You may use any of the items from the box above, or you may have additional ideas of your 
own.
The^most important causes for me:-
1. ___ _ _________________________________
2 .
3 .
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INFORMATION SHEET FOR PATIENTS/VOLUNTEERS IN CLINICAL RESEARCH 
PROJECT ----
Title of Project
Depression in Cancer Patients: An Examination of the Role of Self-Efficacy for Coping with 
Cancer and Dispositional Optimism.
You are being invited to participate in a study being carried out by the Department of 
Psychological Medicine at Glasgow University. The aim of this study is to understand more about 
the links between our coping beliefs, our level of optimism and depression.
Purpose of the Study
Previous research has shown that it can be very difficult to adjust to having cancer, and that often 
people feel depressed due to this. It has been shown that problems like these are often associated 
with our beliefs about how much we will be able to cope with and whether we expect good or bad 
things to happen to us. It is hoped that this research will help to prevent difficulties with coping 
with cancer from developing into more serious problems like depression.
Procedure
If you choose to participate in this study you will be asked to sign a consent form indicating that 
you have agreed to take part. You will then be asked to complete some questionnaires relating to 
you feelings about your illness, how you are coping, and about your mood and thoughts
generally. Involvement in this study will take approximately one hour of your time.
It should be noted that participation in this study may be of no direct benefit to you, but could 
help in the development of treatment, which could benefit future patients. All information you 
give as part of this research will be treated as confidential. If you wish to take part in this research 
then your GP and consultant oncologist will be informed of this. If any of your responses indicate 
that your mood is very low or that you are very distressed then Ms Wyne can discuss with you 
how to get help with this, and with your consent inform your consultant. If you do not wish to 
participate in this study in this study or wish to withdraw at any time after being involved, your 
care will in no way be affected. If you want to discuss this research further or you have any
questions you would like answered then please contact:
Ms Tara Wyne,
Department of Psychological Medicine,
Academic Centre,
Gartnavel Royal Hospital,
1055 Great Western Road, Glasgow.
Tel No: 0141 211 3941 ^
Thank you for your interest in this study.
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CONSENT FORM
Depression in Cancer Patients: An Examination of the Role of Self-Efficacy for Coping with 
Cancer and Dispositional Optimism.
By signing this form you give consent to you participation in the project whose title is at the top 
of this page. You should have been given a complete explanation of the project to your 
satisfaction and have been given the opportunity to ask questions. You should have been given a 
copy of the participant information sheet to read and keep. Even though you have agreed to take 
part in this research, you may withdraw your consent at any time, without the need to explain 
why and without prejudice to your care.
Consent:
1,........................................................................................................................(PRINT)
O f ...................................................................................................................
Give my consent to the research procedures above, the nature, purpose and possible consequences 
of which have been explained to me.
By.................................................................................................................
Patients signature............................................................. Date...................
Doctor’s signature
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PART OF THE NORTII GLASGOW UNIVERSITY 110SP1TALS N1 IS TRUST
WEST ETHICS COMMITTEE 
Western Infirmary
ANT Dumbarton Road
Glasgow G il 6NT
Direct Line: 211 6238
Mrs A II Torric Fax: 211 1920
SECRETARY - WEST ETHICS COMMITTEE
e:mail - andrea.torrie.wg@norlhglasgow.scot.nhs.uk 
18 October, 2000 
Ms T Wyne
Department o f  Psychological Medicine 
Academic Centre 
Gartnavel Royal Hospital 
Glasgow
Dear Ms Wyne,
00/100(2) Ms T Wyne - Depression in Cancer patients: An examination of the 
role of self efficacy for coping with Cancer and Dispositional 
Optimism
The Committee at the meeting held on 17 October, 2000 ratified Chairman’s approval given in his letter 
dated I 1th October, 2000. This study now has full and unqualified Ethics Committee approval.
Please note that the approval contained in this letter is valid for all sites which form part o f  the North 
Glasgow Trust. If however, this research is to be carried out at sights within the North Glasgow Trust 
other than the one covered by this letter, then a covering letter signed by the person responsible for the 
research on that site should be sent listing names, titles and addresses o f  all collaborating researchers.
A copy of this approval letter should also be passed to them.
It should be noted that although Ethics Committee approval has been granted, Trust Management 
approval is still required. This should be obtained through the Research & Development Office at 
Gartnavel General Hospital (Miss W Burton tel No. 0115).
Due to the large volume of trivial and expected Serious Adverse Events (SAEs) being reported to the 
Committee, the Committee has taken the decision that they only wish to review SAEs where they are 
serious and unexpected and where the investigator believes them to be unusual for the study 
under consideration.
In situations where the study has a Data Monitoring Committee, then the Ethics Committee would only 
require .sight o f  the summarised data at regular intervals o f  6 months rather than individual reports.
In respect o f  MREC approved studies, only events which fall into the above categories and have oceurcd 
ai om local silc should be passed to the Committee. All other events should be reviewed by MREC and 
should not come before this Committee.
Our Ref:
Your Ref: 
Please reply to:
Incorporating the Western Intirmary, Gartnavel General Hospital,
The Glasgow Homoeopathic Hospital. Drumchapol Hospilal and fdlawai thill Hospilnl
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The Committee would like to remind investigators that a copy o f  the Patient Information Sheet and 
Consent Form should be given to patient/volunteers for retaining.
Kind regards.
Yours sincerely,
Andrea 11 Torrie
SECRETRA R Y  - W EST E T fllC S  C O M M IT T E E
Appendix 4.1
Data used to calculate power
M eans for the CBI as a function o f  the high versus low (dichotomised) scores on 
Helplessness/Hopelessness scale o f  the M ental Adjustment to Cancer Scale.
G roup One -  CBI mean and standard deviation = 229.12 ± 30.62 
G roup Two - CBI mean and standard deviation = 207.18 ± 46.58
